Processing 00000000.tx.1: Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene M. 

Phrase: "Risk for Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "correlates with transcriptional activity of the APOE gene M."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C1412481:APOE gene [Gene or Genome]
           APOE
   742   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0017337:Gene [Gene or Genome]
   742   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   742   C0205177:Activity [Functional Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0441923:M+ [Intellectual Product]
   742   C0523511:APOE [Laboratory Procedure]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.2: J. 

Phrase: "J."
Processing 00000000.tx.3: Artiga+, M. 

Phrase: "Artiga+,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: J. 

Phrase: "J."
Processing 00000000.tx.5: Bullido+, A. 

Phrase: "Bullido+,"

Phrase: "A."
Processing 00000000.tx.6: Frank1, I. 

Phrase: "Frank1,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.7: Sastre, M. 

Phrase: "Sastre,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.8: Recuero, M. 

Phrase: "Recuero,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: A. 

Phrase: "A."
Processing 00000000.tx.10: Garca, C. 

Phrase: "Garca,"

Phrase: "C."
Processing 00000000.tx.11: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.12: Lendon2, S. 

Phrase: "Lendon2,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.13: W. 

Phrase: "W."
Processing 00000000.tx.14: Han2, J. 

Phrase: "Han2,"

Phrase: "J."
Processing 00000000.tx.15: C. 

Phrase: "C."
Processing 00000000.tx.16: Morris2, J. 

Phrase: "Morris2,"

Phrase: "J."
Processing 00000000.tx.17: Vzquez, A. 

Phrase: "Vzquez,"

Phrase: "A."
Processing 00000000.tx.18: Goate2 and F. 

Phrase: "Goate2"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.19: Valdivieso* Departamento de Biologa Molecular and Centro de Biologa Molecular Severo Ochoa (CSIC-UAM), Universidad Autnoma de Madrid, Cantoblanco, 28049 Madrid, Spain, 1Servicio de Neurologa, Hospital Universitario La Paz (UAM), 28034 Madrid, Spain and 2Departments of Psychiatry, Neurology and Genetics, Washington University School of Medicine, St Louis, MO 63110, USA Received May 21, 1998; 

Phrase: "Valdivieso"

Phrase: "* Departamento de Biologa"

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Centro de Biologa Molecular Severo Ochoa"

Phrase: "(CSIC-UAM"

Phrase: ")"

Phrase: ","

Phrase: "Universidad Autnoma de Madrid,"

Phrase: "Cantoblanco,"

Phrase: "28049 Madrid,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "1Servicio de Neurologa,"

Phrase: "Hospital Universitario La Paz"

Phrase: "(UAM"

Phrase: ")"

Phrase: ","

Phrase: "28034 Madrid,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "2Departments of Psychiatry,"

Phrase: "Neurology"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "and"

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO 63110,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "May 21,"

Phrase: "1998"

Phrase: ";"
Processing 00000000.tx.20: Revised and Accepted August 18, 1998 While the [epsis]4 allele of apolipoprotein E (APOE, gene; ApoE, protein) is widely accepted as a major genetic risk factor for the late onset form of Alzheimer's disease (AD), recent evidence points to variations in ApoE levels as another important factor. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted August 18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998"

Phrase: "While"

Phrase: "the [epsis"

Phrase: "]4 allele of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]

Phrase: "(APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "; ApoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "is"

Phrase: "widely"

Phrase: "accepted as a major genetic risk factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   804   C0814299:factor genetic risk [Qualitative Concept]
   778   C0035648:Risk factor [Quantitative Concept]
   778   C1517512:Genetic Risk [Quantitative Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205164:Major [Qualitative Concept]
   748   C0314603:Genetic [Functional Concept]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1548435:Accepted [Idea or Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C1548601:Accept [Idea or Concept]

Phrase: "for the late onset form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "points to variations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205419:variations [Qualitative Concept]
   790   C1552961:Point [Quantitative Concept]
   790   C2347617:point [Quantitative Concept]

Phrase: "in ApoE levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "as another important factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.21: We have previously reported that a common variant in the regulatory region of APOE (-491A) is associated with risk for late onset AD. 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a common variant in the regulatory region of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variant [Qualitative Concept]

Phrase: "(-491A"

Phrase: ")"

Phrase: "is"

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for late onset AD."
Processing 00000000.tx.22: In this report we analyze the association of another APOE promoter polymorphism (-427T/C) with AD in two case-control clinical samples and demonstrate a correlation between APOE promoter transcriptional activity and risk for AD. 

Phrase: "In this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "analyze"

Phrase: "the association of another APOE promoter polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(-427T/C) with AD"

Phrase: "in two case-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "clinical samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "demonstrate"

Phrase: "a correlation between APOE promoter transcriptional activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.23: The association studies show that the allelic variant (-427C) and the haplotype [-491A-427C] of the APOE promoter are associated with increased risk for AD. 

Phrase: "The association studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the allelic variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(-427C"

Phrase: ")"

Phrase: "and"

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "[-491A-427C"

Phrase: "]"

Phrase: "of the APOE promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD."
Processing 00000000.tx.24: Study of the transcriptional activity of the common haplotypes defined by combination of the -491 and -427 alleles indicated that the risk for late onset AD positively correlates with transcriptional activity of the APOE gene, suggesting that increases in the local expression of ApoE could be responsible for the association of APOE promoter polymorphism with AD. 

Phrase: "Study of the transcriptional activity of the common haplotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C2348552:Study Activity [Research Activity]
   742   C0557651:Study [Manufactured Object]
   742   C2603343:Study [Research Activity]
   726 E C2347179:Active Study [Functional Concept]

Phrase: "defined by combination of the -491"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205195:Combination [Qualitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C1947911:Combination [Physical Object]
   753   C3539106:Defined [Intellectual Product]

Phrase: "and -"

Phrase: "427 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the risk for late onset AD positively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035647:Risk [Qualitative Concept]

Phrase: "correlates with transcriptional activity of the APOE gene,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1412481:APOE gene [Gene or Genome]
           APOE
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that increases in the local expression of ApoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "responsible for the association of APOE promoter polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "with AD."
Processing 00000000.tx.25: INTRODUCTION Alzheimer's disease (AD), the most common cause of dementia in the elderly, exists in both familial and sporadic forms. 

Phrase: "INTRODUCTION Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "the most common cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]

Phrase: "exists in both familial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]
Processing 00000000.tx.26: Genetic studies have led to the identification of three genes, [beta]-amyloid precursor protein (APP) (1), presenilin-1 (2) and presenilin-2 (3), which, when mutated, can cause autosomal dominant forms of familial AD. 

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "led to the identification of three genes,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   748   C0017337:Genes [Gene or Genome]
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "[beta]-amyloid precursor protein (APP)"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which,"

Phrase: "when"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal dominant forms of familial AD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1832428:Familial form [Finding]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.27: However, mutations in these three genes are responsible for only a small fraction of AD cases, while the vast majority of patients with AD presents with a late age at onset and shows non-Mendelian inheritance. 

Phrase: "However,"

Phrase: "mutations in these three genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "responsible for only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "a small fraction of AD cases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "while"

Phrase: "the vast majority of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "with AD"

Phrase: "presents with a late age at onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0206132:Onset Age [Quantitative Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0150312:Present [Quantitative Concept]
   748   C0205087:Late [Temporal Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "non-Mendelian inheritance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683231:Mendelian inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]
Processing 00000000.tx.28: The absence of Mendelian inheritance indicates that late onset AD is a complex disease in which genetic and non-genetic factors are likely to be interacting. 

Phrase: "The absence of Mendelian inheritance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "indicates"

Phrase: "that late onset AD"

Phrase: "is"

Phrase: "a complex disease in which genetic"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0019247:Genetic disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   742 E C2316203:Genetic diseases [Finding]
   742 E C2924406:Genetic diseases [Laboratory Procedure]

Phrase: "and"

Phrase: "non-genetic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "interacting."
Processing 00000000.tx.29: The [epsis]4 allele of apolipoprotein E (APOE, gene; ApoE, protein) has been associated with an increased risk of developing AD (4). 

Phrase: "The [epsis"

Phrase: "]4 allele of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]

Phrase: "(APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "; ApoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "associated with an increased risk of developing AD (4"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.30: However, many AD cases have no APOE [epsis]4 alleles. 

Phrase: "However,"

Phrase: "many AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "no APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsis"

Phrase: "]4 alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.31: Thus it is likely that there are additional AD risk factors, both genetic and environmental, still to be identified. 

Phrase: "Thus"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "additional AD risk factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035648:risk factors [Quantitative Concept]
   861   C1553898:risk factors [Idea or Concept]
   812   C0035647:Risk [Qualitative Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "both genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "environmental, still to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environmental [Spatial Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.32: We have screened for genetic variability in the proximal promoter region of APOE (nt -1017 to +406) and observed three new polymorphic sites (-491, -427 and -219) (5) and a previously described one (+113) (6) within this region. 

Phrase: "We"

Phrase: "have"

Phrase: "screened for genetic variability"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   802   C0813145:Genetic screen [Diagnostic Procedure]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C2827666:Variability [Conceptual Entity]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "in the proximal promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "(nt -1017 to +406"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332126:NT [Qualitative Concept]
   812   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "observed three new polymorphic sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "(-491, -"

Phrase: "427"

Phrase: "and -"

Phrase: "219"

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a previously described one (+113"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205447:One [Quantitative Concept]
   812   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: "(6"

Phrase: ")"

Phrase: "within this region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.33: We have recently reported that one of these variants (-491A) is associated with risk for AD (7). 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that one of these variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(-491A"

Phrase: ")"

Phrase: "is"

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD (7"

Phrase: ")."
Processing 00000000.tx.34: We now report that the allelic variant -427C of the APOE promoter is also associated with AD, whereas we found no significant association of -219 and +113 polymorphisms with risk for AD. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the allelic variant -427C of the APOE promoter"

Phrase: "is"

Phrase: "also"

Phrase: "associated with AD,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "whereas"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant association of -219"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0004083:Association [Mental Process]
   812   C0237881:significant [Quantitative Concept]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]
   812   C0750502:Significant [Idea or Concept]
   812   C1546944:Significant [Qualitative Concept]

Phrase: "and +"

Phrase: "113 polymorphisms with risk"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for AD."
Processing 00000000.tx.35: Results from others have suggested that the -219 polymorphism acts as a modifier of ApoE4- associated risk (8). 

Phrase: "Results from others"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the -219 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "acts as a modifier of ApoE4- associated risk"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0035647:Risk [Qualitative Concept]
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0205349:Modifier [Qualitative Concept]
   744   C0332281:Associated [Qualitative Concept]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C2984964:APOE4 [Laboratory Procedure]
   744   C3542952:Modifier [Intellectual Product]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.36: Study of the transcriptional activity of the haplotypes defined by combination of the -491 and -427 alleles indicates that the risk for late onset AD correlates with transcriptional activity of the APOE gene. 

Phrase: "Study of the transcriptional activity of the haplotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C2348552:Study Activity [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]
   731 E C2347179:Active Study [Functional Concept]

Phrase: "defined by combination of the -491"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205195:Combination [Qualitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C1947911:Combination [Physical Object]
   753   C3539106:Defined [Intellectual Product]

Phrase: "and -"

Phrase: "427 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "indicates"

Phrase: "that"

Phrase: "the risk for late onset AD correlates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035647:Risk [Qualitative Concept]

Phrase: "with transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of the APOE gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.37: RESULTS During our screening of the transcriptional regulatory region of the APOE gene a novel polymorphic site (-427T/C) was identified (5). 

Phrase: "RESULTS During our screening of the transcriptional regulatory region of the APOE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   732   C1519205:Screening Result [Conceptual Entity]
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "a novel polymorphic site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(-427T/C)"

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: The possible genetic association of this polymorphism with risk for AD was studied in a Spanish case-control sample, in which we had previously observed an association between the polymorphism at position -491 of the APOE promoter and risk for AD (7). 

Phrase: "The possible genetic association of this polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for AD"

Phrase: "was"

Phrase: "studied in a Spanish case-control sample,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   793   C0007328:Case-Control Study [Research Activity]
   778   C0872128:case control [Health Care Activity]
   757   C0085973:Case Study [Intellectual Product]
   748   C0086409:SPANISH [Population Group]
   748   C0243148:control [Qualitative Concept]
   748   C0370003:Sample [Substance]
   748   C0868928:Case [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]
   748   C1882979:Control [Conceptual Entity]
   748   C2347026:Sample [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3161473:Spanish [Population Group]
   748   C3274648:Control [Qualitative Concept]
   714   C0557651:Study [Manufactured Object]
   714   C2603343:Study [Research Activity]

Phrase: "in which"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an association between the polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "at position -491"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "of the APOE promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "risk for AD (7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.39: The genotype and allele distributions for the -427T/C polymorphism are shown in Table 1. 

Phrase: "The genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele distributions for the -427T/C polymorphism"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.40: The TC genotype and the C allele were more frequent, although differences did not achieved statistical significance, in the AD group than in the controls, suggesting that they were associated with an increased risk for AD [odds ratio (OR) 1.87, 95% confidence interval (CI) 0.90-3.91 for the TC genotype and OR 1.78, 95% CI 0.88-3.62 for the C allele]. 

Phrase: "The TC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "the C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "more frequent,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0332183:Frequent [Temporal Concept]
   789 E C0376249:frequency [Quantitative Concept]
   789 E C0439603:Frequencies [Temporal Concept]
   789 E C0871396:Frequency [Quantitative Concept]
   789 E C1561548:Frequency [Qualitative Concept]
   789 E C1705502:Frequency [Quantitative Concept]

Phrase: "although"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieved"

Phrase: "statistical significance,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "in the AD group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "than"

Phrase: "in the controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD [odds ratio (OR) 1.87,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0028873:Odds Ratio [Quantitative Concept]
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "95% confidence interval (CI) 0.90-3.91"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C0439083:>90 [Quantitative Concept]
   795   C0439087:<90 [Quantitative Concept]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: "for the TC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "OR 1.78,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "95% CI 0.88-3.62"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: "for the C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "]."
Processing 00000000.tx.41: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.42: APOE 427T/C genotype and allele frequencies (f) in Spain; 

Phrase: "APOE 427T/C genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "allele frequencies (f) in Spain"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   833   C0017270:Frequencies, Allele [Quantitative Concept]
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.43: age at onset >60 years ApoE4 status Genotype: n (f) Allele: n (f) TT TC CC T C Whole sample Cases 90 (0.82) 20 (0.18) 0 200 (0.91) 20 (0.09) Controls 118 (0.89) 14 (0.11) 0 250 (0.95) 14 (0.05) ApoE4 non-carriers (-/-) Cases 28 (0.72) 11 (0.28) 0 67 (0.86) 11 (0.14) Controls 103 (0.90) 12 (0.10) 0 218 (0.95) 12 (0.05) Carriers (-/+, +/+) Cases 62 (0.87) 9 (0.13) 0 133 (0.94) 9 (0.06) Controls 15 (0.88) 2 (0.12) 0 32 (0.94) 2 (0.06) 2  2 [chi]2 tests to compare TT and TC genotype frequency in AD versus controls were performed: whole sample, P > 0.05; 

Phrase: "age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ">60 years ApoE4 status Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017431:Genotype [Organism Attribute]

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "Allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "TT TC CC T C Whole sample Cases 90"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   791   C0041405:TC [Geographic Area]
   791   C0370003:Sample [Substance]
   791   C0439083:>90 [Quantitative Concept]
   791   C0439087:<90 [Quantitative Concept]
   791   C0444667:Whole [Quantitative Concept]
   791   C0868928:Cases [Functional Concept]
   791   C1533148:Cases [Quantitative Concept]
   791   C1824670:TC [Gene or Genome]
   791   C2347026:Sample [Conceptual Entity]
   791   C3272447:TC [Gene or Genome]
   791   C3538933:CC [Cell Component]
   758 E C1706255:CASE [Medical Device]
   758 E C1706256:Case [Conceptual Entity]

Phrase: "(0.82"

Phrase: ")"

Phrase: "20"

Phrase: "(0.18"

Phrase: ")"

Phrase: "0 200"

Phrase: "(0.91"

Phrase: ")"

Phrase: "20"

Phrase: "(0.09"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "118"

Phrase: "(0.89"

Phrase: ")"

Phrase: "14"

Phrase: "(0.11"

Phrase: ")"

Phrase: "0 250"

Phrase: "(0.95"

Phrase: ")"

Phrase: "14"

Phrase: "(0.05"

Phrase: ")"

Phrase: "ApoE4 non-carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007294:carriers [Finding]
   827   C1518422:Non [Functional Concept]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "(-/-"

Phrase: ")"

Phrase: "Cases 28"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(0.72"

Phrase: ")"

Phrase: "11"

Phrase: "(0.28"

Phrase: ")"

Phrase: "0 67"

Phrase: "(0.86"

Phrase: ")"

Phrase: "11"

Phrase: "(0.14"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "103"

Phrase: "(0.90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "12"

Phrase: "(0.10"

Phrase: ")"

Phrase: "0 218"

Phrase: "(0.95"

Phrase: ")"

Phrase: "12"

Phrase: "(0.05"

Phrase: ")"

Phrase: "Carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "(-/+,"

Phrase: "+/+"

Phrase: ")"

Phrase: "Cases 62"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(0.87"

Phrase: ")"

Phrase: "9"

Phrase: "(0.13"

Phrase: ")"

Phrase: "0 133"

Phrase: "(0.94"

Phrase: ")"

Phrase: "9"

Phrase: "(0.06"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "15"

Phrase: "(0.88"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(0.12"

Phrase: ")"

Phrase: "0 32"

Phrase: "(0.94"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(0.06"

Phrase: ")"

Phrase: "2  2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[chi]2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1720589:Chi [Intellectual Product]

Phrase: "tests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:Tests [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "TT"

Phrase: "and"

Phrase: "TC genotype frequency in AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "versus"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ":"

Phrase: "whole sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.44: ApoE4 carriers, P > 0.05; 

Phrase: "ApoE4 carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.45: ApoE4 non-carriers, P = 0.007. 

Phrase: "ApoE4 non-carriers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007294:carriers [Finding]
   827   C1518422:Non [Functional Concept]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "P = 0.007."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.46: In order to determine whether the variation in risk for AD associated with the -427T/C polymorphism was independent of the risk conferred by ApoE4, the sample was stratified on the basis of the absence or presence of the ApoE4 allele (Table 1). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the variation in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "for AD"

Phrase: "associated with the -427T/C polymorphism"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was independent of the risk"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0332291:Independent of [Functional Concept]
   760   C0035647:Risk [Qualitative Concept]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0085862:Independent [Idea or Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1299583:Independent [Finding]
   760   C1421478:WAS [Gene or Genome]

Phrase: "conferred by ApoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "stratified on the basis of the absence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205363:Stratified [Qualitative Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "or"

Phrase: "presence of the ApoE4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.47: No difference in the frequency of the -427C allele or the -427TC genotype was observed between the AD patients and controls bearing one or two ApoE4 alleles, but the -427C allele was clearly associated with increased risk for AD in individuals bearing no ApoE4 alleles (OR 3.00, 95% CI 1.26-7.07). 

Phrase: "No difference in the frequency of the -427C allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "the -427TC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "observed between the AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "bearing one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "two ApoE4 alleles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C3642141:APOE*4 Allele [Gene or Genome]
   827   C0002085:Alleles [Gene or Genome]

Phrase: "but"

Phrase: "the -427C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "clearly"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD"

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "no ApoE4 alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Alleles [Gene or Genome]

Phrase: "(OR 3.00,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "95% CI 1.26-7.07"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: ")."
Processing 00000000.tx.48: Similarly, the -427TC genotype was associated with a >3-fold increase in risk for AD in the same subpopulation (OR 3.37, 95% CI 1.35-8.45), indicating that the variation in risk for AD conferred by the -427T/C polymorphism is only apparent in individuals not carrying any ApoE4 allele. 

Phrase: "Similarly,"

Phrase: "the -427TC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "associated with a >3-fold increase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for AD"

Phrase: "in the same subpopulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1257890:Subpopulation [Population Group]

Phrase: "(OR 3.37,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "95% CI 1.35-8.45"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the variation in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:Variation [Qualitative Concept]

Phrase: "for AD"

Phrase: "conferred by the -427T/C polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "only apparent in individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "any ApoE4 allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.49: The same trend was observed in the US group of individuals bearing no ApoE4 alleles (OR 1.40, 95% CI 0.65-3.01 for the TC genotype), although the differences in allelic frequencies did not achieve statistical significance in this population. 

Phrase: "The same trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "observed in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "US group of individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "no ApoE4 alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Alleles [Gene or Genome]

Phrase: "(OR 1.40,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0439509:/40 [Temporal Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "95% CI 0.65-3.01"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C0450385:65 [Intellectual Product]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: "for the TC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the differences in allelic frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "statistical significance in this population."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.50: Since the -427T/C and -491A/T polymorphisms are located very close to each other within the proximal 5[prime]-flanking region of the APOE gene and both of them appeared to be associated with risk for developing AD, we analyzed their effect on AD risk when combined into haplotypes. 

Phrase: "Since"

Phrase: "the -427T/C"

Phrase: "and -"

Phrase: "491A/T polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "located"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0587267:Close [Functional Concept]

Phrase: "within the proximal 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205107:Proximal [Spatial Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-flanking region of the APOE gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0230171:flanking [Body Location or Region]

Phrase: "and"

Phrase: "both of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for developing AD,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "their effect on AD risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1883473:Ad Effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "when"

Phrase: "combined into haplotypes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018591:Haplotypes [Organism Attribute]
   790   C0205195:Combined [Qualitative Concept]
   756 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.51: We first analyzed the [-491-427] haplotype distribution in both the Spanish and US samples. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the [-491-427"

Phrase: "] haplotype distribution in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "the Spanish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086409:SPANISH [Population Group]
  1000   C3161473:Spanish [Population Group]

Phrase: "and"

Phrase: "US samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.52: A combined digestion of an APOE fragment spanning nt -512 to -285 with DraI and AluI was performed, which allowed identification of the four haplotypes and the 10 genotypes defined by the combination of the -491 and -427 alleles. 

Phrase: "A combined digestion of an APOE fragment spanning nt -512 to -285"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0012238:Digestion [Organism Function]
   736   C2349986:Digestion [Research Activity]

Phrase: "with DraI"

Phrase: "and"

Phrase: "AluI"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "which"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "identification of the four haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "the 10 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "defined by the combination of the -491"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205195:Combination [Qualitative Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C1947911:Combination [Physical Object]
   748   C3539106:Defined [Intellectual Product]

Phrase: "and -"

Phrase: "427 alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.53: Haplotype [A-T] [-491-427] was the most common, followed by [T-T] and [A-C]. 

Phrase: "Haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "[A-T] [-491-427"

Phrase: "]"

Phrase: "was"

Phrase: "the most common,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "followed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332283:Followed by [Temporal Concept]
           followed
   799 E C1719822:Follow [Intellectual Product]

Phrase: "[T-T]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and ["

Phrase: "A-C]."
Processing 00000000.tx.54: No subjects with the T-C haplotype were found in either sample. 

Phrase: "No subjects with the T-C haplotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "found in either sample."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.55: The distribution of these haplotypes in genotypes was close to that expected under Hardy-Weinberg equilibrium ([chi]2 test, P > 0.5). 

Phrase: "The distribution of these haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "was"

Phrase: "close to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "expected under Hardy-Weinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Equilibrium [Organism Function]
   760   C1517001:Expected [Idea or Concept]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "("

Phrase: "[chi]2 test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "P > 0.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0444499:0/5 [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.56: Furthermore, no statistically significant evidence of linkage disequilibrium between these polymorphisms was detected ([chi]2 test, P = 0.3). 

Phrase: "Furthermore,"

Phrase: "no statistically significant evidence of linkage disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "[chi]2 test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "P = 0.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.57: The most frequent genotype was [A-T]/[A-T], followed by [A-T]/[T-T] and [A-T]/[A-C]; 

Phrase: "The most frequent genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "was ["

Phrase: "A-T]/[A-T"

Phrase: "],"

Phrase: "followed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332283:Followed by [Temporal Concept]
           followed
   799 E C1719822:Follow [Intellectual Product]

Phrase: "[A-T]/[T-T]"

Phrase: "and ["

Phrase: "A-T]/["
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "A-C]"

Phrase: ";"
Processing 00000000.tx.58: these three genotypes accounted for >92% of both the Spanish and St Louis control populations. 

Phrase: "these three genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: ">92% of both"

Phrase: "the Spanish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086409:SPANISH [Population Group]
  1000   C3161473:Spanish [Population Group]

Phrase: "and"

Phrase: "St Louis control populations."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0032662:control population [Occupation or Discipline]
   812   C0032659:Population [Quantitative Concept]
   812   C0243148:control [Qualitative Concept]
   812   C1257890:Population [Population Group]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.59: The frequency of genotypes [T-T]/[T-T] and [A-C]/[T-T] was <5% and the frequencies of the other genotypes ranged from 0 to 2%. 

Phrase: "The frequency of genotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "[T-T]/[T-T]"

Phrase: "and ["

Phrase: "A-C]/[T-T]"

Phrase: "was <"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "the frequencies of the"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "other genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "ranged from 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 2%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.60: The distribution of the major haplotypes and genotypes in the Spanish and St Louis samples is shown in Table 2. 

Phrase: "The distribution of the major haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "genotypes in the Spanish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "St Louis samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.61: Since our previous study had revealed differences in transcription associated with the -491 polymorphism (5,7), we then examined the functional characteristics of the major [-491-427] haplotypes present in our populations. 

Phrase: "Since"

Phrase: "our previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "revealed differences in transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "associated with the -491 polymorphism"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the functional characteristics of the major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "[-491-427"

Phrase: "] haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "present in our populations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032659:Population [Quantitative Concept]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1257890:Population [Population Group]
Processing 00000000.tx.62: The APOE proximal promoter activity of the three haplotypes ([T-T], [A-T] and [A-C]) was measured in U87 human astrocytoma cells using the same luciferase-based transient transfection system employed in our previous studies (5,7,19). 

Phrase: "The APOE proximal promoter activity of the three haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "[T-T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "],"

Phrase: "[A-T]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "A-C])"

Phrase: "was"

Phrase: "measured in U87 human astrocytoma cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0004114:Astrocytoma [Neoplastic Process]
   753   C0007634:Cells [Cell]
   753   C0086418:Human [Human]
   753   C0444706:Measured [Qualitative Concept]
   753   C1822629:U87 [Gene or Genome]
   753   C1822997:U87 [Gene or Genome]
   753   C3282337:Cells [Cell]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same luciferase-based transient transfection system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "employed in our previous studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0557351:Employed [Finding]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   726 E C0457083:Employ [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.63: As shown in Figure 1, transcriptional activity of haplotypes [A-T] and [A-C] were increased by 30 and 100%, respectively, over that of haplotype [T-T], suggesting that the presence of the alleles conferring increased risk for AD (-491A and -427C) is associated with increased constitutive levels of APOE promoter activity in human astrocytoma cells. 

Phrase: "As"

Phrase: "shown in Figure 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "transcriptional activity of haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "[A-T]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "A-C]"

Phrase: "were"

Phrase: "increased by 30"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "100%,"

Phrase: "respectively,"

Phrase: "over"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]

Phrase: "that of haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018591:Haplotype [Organism Attribute]

Phrase: "[T-T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "],"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the presence of the alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "conferring"

Phrase: "increased risk for AD (-491A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "and -"

Phrase: "427C"

Phrase: ")"

Phrase: "is"

Phrase: "associated with increased constitutive levels of APOE promoter activity"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0474395:increased activity [Finding]
   762   C0683317:activity levels [Finding]
   742   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205177:Activity [Functional Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0441889:Levels [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0523511:APOE [Laboratory Procedure]
   742   C1412481:APOE [Gene or Genome]
   742   C1561536:*Activity [Idea or Concept]
   708 E C0456079:Level [Classification]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1547707:Level [Geographic Area]
   708 E C1706221:Associate [Professional or Occupational Group]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in human astrocytoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0427861:Human cells [Laboratory or Test Result]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.64: The three haplotypes [T-T], [A-T] and [A-C] were thus named minus (-), even (x) and plus (+), respectively, according to their transcriptional activity. 

Phrase: "The three haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "[T-T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "],"

Phrase: "[A-T]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "A-C]"

Phrase: "were"

Phrase: "thus"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "(-"

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "(x)"

Phrase: "and plus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332287:Plus [Qualitative Concept]
   833   C1515981:And [Idea or Concept]

Phrase: "(+"

Phrase: ")"

Phrase: ","

Phrase: "respectively,"

Phrase: "according to their transcriptional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.65: Additional information was obtained using oligonucleotide probes corresponding to the -491 and -427 allelic forms in electrophoretic mobility shift assays, with freshly prepared nuclear extracts from U87 cells. 

Phrase: "Additional information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1546922:Additional information [Temporal Concept]
  1000   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligonucleotide probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028952:Oligonucleotide Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the -491"

Phrase: "and -"

Phrase: "427 allelic forms in electrophoretic mobility shift assays,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "with freshly"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "nuclear extracts from U87 cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0007592:Cell Extracts [Cell Component]
   773   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0521447:Nuclear [Spatial Concept]
   726   C2828366:Extract [Substance]
Processing 00000000.tx.66: As shown in Figure 2, one of the three specific band shifts detected by the 427T probe (arrows) was not detected by the 427C probe, suggesting that the T->C substitution hinders binding of the probe to a nuclear protein. 

Phrase: "As"

Phrase: "shown in Figure 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "one of the three specific band shifts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "detected by the 427T probe"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0182400:Probe [Medical Device]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected by the 427C probe,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0182400:Probe [Medical Device]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the T->C substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "hinders"

Phrase: "binding of the probe"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0182400:Probe [Medical Device]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "to a nuclear protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]
Processing 00000000.tx.67: This finding is in agreement with the data obtained in our previous work using the 491 probes (7) and strongly suggests that differential transcriptional activities of the three [-491-427] haplotypes encountered in astrocytoma cells are a consequence of differential binding to nuclear proteins present in these cells. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained in our previous work"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0043227:Work [Occupational Activity]
   760   C0205156:Previous [Temporal Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1552607:previous [Temporal Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 491 probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "strongly"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that differential transcriptional activities of the three"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "[-491-427"

Phrase: "] haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "encountered in astrocytoma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0004114:Astrocytoma [Neoplastic Process]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0545082:Encounter [Behavior]
   737 E C1269647:Cell [Cell]
   737   C1512346:encounter [Health Care Activity]
   737 E C1704653:Cell [Medical Device]
   737   C1947978:Encounter [Behavior]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "a consequence of differential binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "to nuclear proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "present in these cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.68: Table 2. 

Phrase: "Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.69: APOE [-491-427] major genotype and haplotype frequencies (f); 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[-491-427"

Phrase: "] major genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "(f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.70: age at onset >60 years  Genotype: n (f) Haplotype: n (f) [A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] [A-T] [T-T] [A-C] Spain (Madrid) Cases 68 (0.62) 17 (0.15) 20 (0.18) 173 (0.79) 27 (0.12) 2 (0.09) Controls 62 (0.47) 50 (0.38) 10 (0.08) 184 (0.70) 66 (0.25) 14 (0.05) USA (St Louis) Cases 104 (0.65) 24 (0.15) 27 (0.17) 259 (0.80) 33 (0.10) 30 (0.09) Controls 96 (0.55) 42 (0.24) 23 (0.13) 258 (0.73) 60 (0.17) 32 (0.09) 2  2 [chi]2 test of [A-T]/[A-C] versus [A-T]/[T-T]: Spain, P = 0.0001; 

Phrase: "age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ">60 years  Genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "Haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "[A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] [A-T] [T-T] [A-C] Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0037747:Spain [Geographic Area]

Phrase: "(Madrid"

Phrase: ")"

Phrase: "Cases 68"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0450387:68 [Intellectual Product]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(0.62"

Phrase: ")"

Phrase: "17"

Phrase: "(0.15"

Phrase: ")"

Phrase: "20"

Phrase: "(0.18"

Phrase: ")"

Phrase: "173"

Phrase: "(0.79"

Phrase: ")"

Phrase: "27"

Phrase: "(0.12"

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(0.09"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "62"

Phrase: "(0.47"

Phrase: ")"

Phrase: "50"

Phrase: "(0.38"

Phrase: ")"

Phrase: "10"

Phrase: "(0.08"

Phrase: ")"

Phrase: "184"

Phrase: "(0.70"

Phrase: ")"

Phrase: "66"

Phrase: "(0.25"

Phrase: ")"

Phrase: "14"

Phrase: "(0.05"

Phrase: ")"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "(St Louis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: ")"

Phrase: "Cases 104"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(0.65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "24"

Phrase: "(0.15"

Phrase: ")"

Phrase: "27"

Phrase: "(0.17"

Phrase: ")"

Phrase: "259"

Phrase: "(0.80"

Phrase: ")"

Phrase: "33"

Phrase: "(0.10"

Phrase: ")"

Phrase: "30"

Phrase: "(0.09"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "96"

Phrase: "(0.55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "42"

Phrase: "(0.24"

Phrase: ")"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "(0.13"

Phrase: ")"

Phrase: "258"

Phrase: "(0.73"

Phrase: ")"

Phrase: "60"

Phrase: "(0.17"

Phrase: ")"

Phrase: "32"

Phrase: "(0.09"

Phrase: ")"

Phrase: "2  2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[chi]2 test of [A-T]/["

Phrase: "A-C]"

Phrase: "versus"

Phrase: "[A-T]/[T-T"

Phrase: "]"

Phrase: ":"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.71: USA, P = 0.050. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "P = 0.050."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.72: 2  2 [chi]2 test of [A-T]/[A-T] versus [A-T]/[T-T]: Spain, P = 0.0003; 

Phrase: "2  2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[chi]2 test of [A-T]/[A-T]"

Phrase: "versus"

Phrase: "[A-T]/[T-T"

Phrase: "]"

Phrase: ":"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "P = 0.0003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.73: USA, P = 0.027. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "P = 0.027."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.74: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.75: Transcriptional activity of the [-491-427] haplotypes of the APOE promoter. 

Phrase: "Transcriptional activity of the [-491-427"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "] haplotypes of the APOE promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.76: Luciferase:[beta]-galactosidase activity ratios for pXP2 constructs containing the [T-T] (-), [A-T] (x) and [A-C] (+) APOE haplotypes transfected into U87 astrocytoma cells are expressed as percentages of activity of the [T-T] construct. 

Phrase: "Luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ":"

Phrase: "[beta]-galactosidase activity ratios for pXP2 constructs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C1150053:beta-galactosidase activity [Molecular Function]
   778   C1150051:galactosidase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the [T-T] (-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "[A-T] (x)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "and ["

Phrase: "A-C] (+) APOE haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "transfected into U87 astrocytoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0004114:Astrocytoma [Neoplastic Process]
   760   C0007634:Cells [Cell]
   760   C1822629:U87 [Gene or Genome]
   760   C1822997:U87 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "expressed as percentages of activity of the [T-T] construct."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
   739   C2827421:Construct [Classification]
   706   C0439165:Percentage [Quantitative Concept]
   706   C1549488:Percentage [Idea or Concept]
   706   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.77: Data are means  SEM of six determinations and are representative of five experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SEM of six determinations"

Phrase: "and"

Phrase: "are"

Phrase: "representative of five experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.78: Figure 2. 

Phrase: "Figure 2."
Processing 00000000.tx.79: Protein binding of the -427T/C allelic forms of the APOE promoter. 

Phrase: "Protein binding of the -427T/C allelic forms"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0033618:Protein Binding [Molecular Function]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "of the APOE promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.80: 32P-labeled -427T and -427C probes were incubated with U87 nuclear extract (NE) and subjected to electrophoretic mobility shift assays. 

Phrase: "32P-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "labeled -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "427T"

Phrase: "and -"

Phrase: "427C probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "incubated with U87 nuclear extract (NE)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1822629:U87 [Gene or Genome]
   760   C1822997:U87 [Gene or Genome]
   760   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "subjected to electrophoretic mobility shift assays."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   849   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assays
   753   C0333051:Shift [Functional Concept]
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]
   753   C2347509:Shift [Phenomenon or Process]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1510438:Assay [Laboratory Procedure]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.81: Competition experiments were performed by pre-incubating the nuclear extract with a 50-fold excess of the unlabeled oligonucleotide before addition of the probe. 

Phrase: "Competition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1550369:Performed By [Qualitative Concept]
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pre-incubating"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C1439852:incubating [Laboratory Procedure]
   861   C2257086:PRE [Genetic Function]

Phrase: "the nuclear extract with a 50-fold excess of the unlabeled oligonucleotide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1518434:Nuclear Extract [Biomedical or Dental Material]
   736   C0521447:Nuclear [Spatial Concept]
   736   C2828366:Extract [Substance]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of the probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.82: Arrows, specific shift bands; 

Phrase: "Arrows,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "specific shift bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: ";"
Processing 00000000.tx.83: asterisk, non-specific band. 

Phrase: "asterisk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "non-specific band."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]
   734   C0205370:Non-specific [Qualitative Concept]
Processing 00000000.tx.84: Results are representative of four independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of four independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.85: Association between APOE promoter activity and risk for AD was then analyzed in the Spanish population stratified according to ApoE status (Table 3). 

Phrase: "Association between APOE promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "risk for AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed in the Spanish population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0032659:Population [Quantitative Concept]
   760   C0086409:SPANISH [Population Group]
   760   C0936012:Analyzed [Research Activity]
   760   C1257890:Population [Population Group]
   760   C3161473:Spanish [Population Group]

Phrase: "stratified according to ApoE status"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205363:Stratified [Qualitative Concept]
   760   C0449438:Status [Qualitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C0680240:according [Social Behavior]
   760   C1412481:APOE [Gene or Genome]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: A strong association between AD risk and promoter activity of the three predominant genotypes (x-, xx and x+) was observed in the Spanish non-ApoE4 individuals; 

Phrase: "A strong association between AD risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "promoter activity of the three predominant genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(x-,"

Phrase: "xx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450371:XX [Organism Attribute]

Phrase: "and"

Phrase: "x+)"

Phrase: "was"

Phrase: "observed in the Spanish non-ApoE4 individuals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   748   C0086409:SPANISH [Population Group]
   748   C1441672:Observed [Functional Concept]
   748   C1518422:Non [Functional Concept]
   748   C2984964:APOE4 [Laboratory Procedure]
   748   C3161473:Spanish [Population Group]
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: ";"
Processing 00000000.tx.87: taking as reference the x- individuals, the risk for AD was found to increase 6- and 18-fold in xx and x+ individuals, respectively. 

Phrase: "taking"

Phrase: "as"

Phrase: "reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "the x- individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "the risk for AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "6-"

Phrase: "and"

Phrase: "18-fold in xx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "x+ individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "respectively."
Processing 00000000.tx.88: Statistical significance of these data was evaluated by a logistic regression model. 

Phrase: "Statistical significance of these data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   797   C2828391:statistical data [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "evaluated by a logistic regression model."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0206031:Logistic Regression [Research Activity]
   783   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   753   C0220825:Evaluated [Functional Concept]
   753   C0242415:logistic [Occupational Activity]
   753   C0684320:Regression [Pathologic Function]
   753   C0684321:Regression [Mental Process]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.89: Analysis of the subgroup of non-E4 carriers showed a highly significant association between AD risk and promoter activity (P < 10-10) and yielded predicted ORs of 4.3 (95% CI 2.9-6.3) and 18 (95% CI 8-40) for genotypes xx and x+, respectively (Fig. 3a). 

Phrase: "Analysis of the subgroup of non-E4 carriers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a highly significant association between AD risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(P < 10-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "yielded"

Phrase: "predicted ORs of 4.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(95% CI 2.9-6.3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: "and"

Phrase: "18"

Phrase: "(95% CI 8-40"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   840   C0009667:Confidence Interval [Quantitative Concept]
   804   C0237529:Confidence [Mental Process]
   804   C0439509:/40 [Temporal Concept]
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]
   804   C1704725:Confidence [Qualitative Concept]
   804   C1704726:Confidence [Mental Process]
   733 E C0558095:Confident [Individual Behavior]
   704 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "for genotypes xx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450371:XX [Organism Attribute]

Phrase: "and"

Phrase: "x+,"

Phrase: "respectively"

Phrase: "(Fig. 3a"

Phrase: ")."
Processing 00000000.tx.90: Figure 3. 

Phrase: "Figure 3."
Processing 00000000.tx.91: Association between risk for AD and APOE promoter genotypes in the (a) Spanish and (b) US non-ApoE4 subpopulations. 

Phrase: "Association between risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "for AD"

Phrase: "and"

Phrase: "APOE promoter genotypes in the (a) Spanish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotypes [Organism Attribute]

Phrase: "and ("

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "US non-ApoE4 subpopulations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1257890:Subpopulation [Population Group]
Processing 00000000.tx.92: The risks are represented on a log odds scale, taking as the reference the genotype x-, which bears the weakest expressing (-) haplotype. 

Phrase: "The risks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risks [Qualitative Concept]

Phrase: "are"

Phrase: "represented on a log odds scale,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0175659:Scale [Medical Device]
   753   C0349674:Scale [Intellectual Product]
   753   C1708728:Log [Intellectual Product]
   753   C1947916:Scale [Activity]
   753   C2986775:log [Occupational Activity]
   753   C3536777:Scale [Manufactured Object]
   719   C1882932:Represent [Activity]

Phrase: "taking as the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1515187:Take [Health Care Activity]

Phrase: "reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "the genotype x-,"

Phrase: "which"

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "the weakest expressing"

Phrase: "(-"

Phrase: ")"

Phrase: "haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.93: Bars represent the calculated ORs. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the calculated ORs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.94: The superimposed line represents the ORs estimated by the logistic regression model and error bars indicate the 95% CIs. 

Phrase: "The superimposed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "estimated by the logistic regression model"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0206031:Logistic Regression [Research Activity]
   783   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   753   C0242415:logistic [Occupational Activity]
   753   C0684320:Regression [Pathologic Function]
   753   C0684321:Regression [Mental Process]
   753   C0750572:Estimated [Quantitative Concept]
   753   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "the 95% CIs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1504308:Cis [Eukaryote]
Processing 00000000.tx.95: Finally, the hypothesis that AD risk increases with promoter transcriptional activity measured in the transfection assays was tested in the St Louis population. 

Phrase: "Finally,"

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that AD risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "increases with promoter transcriptional activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0040649:Transcriptional [Genetic Function]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442805:Increase [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   756   C0474395:increased activity [Finding]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "measured in the transfection assays"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726   C0005507:Assay [Laboratory Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "tested in the St Louis population."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0032659:Population [Quantitative Concept]
   753   C0392366:tested [Intellectual Product]
   753   C1257890:Population [Population Group]
   753   C3272372:ST [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]
Processing 00000000.tx.96: Although the association was less impressive than that encountered in the Spanish population, a similar dependence of OR for developing AD and promoter activity of the three predominant genotypes was detected in the non-E4 subpopulation (Table 3). 

Phrase: "Although"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "less impressive than that"

Phrase: "encountered in the Spanish population,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0032659:Population [Quantitative Concept]
   760   C0086409:SPANISH [Population Group]
   760   C1257890:Population [Population Group]
   760   C3161473:Spanish [Population Group]
   726   C0545082:Encounter [Behavior]
   726   C1512346:encounter [Health Care Activity]
   726   C1947978:Encounter [Behavior]

Phrase: "a similar dependence of OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "for developing AD"

Phrase: "and"

Phrase: "promoter activity of the three predominant genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected in the non-E4 subpopulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442726:Detected [Finding]
   753   C1257890:Subpopulation [Population Group]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1518422:Non [Functional Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.97: The logistic regression analysis indicated a highly statistically significant association between AD risk and promoter activity (P < 10-10), with ORs of 1.4 (95% CI 1.3-1.5) and 2.0 (95% CI 1.9-2.2) for genotypes xx and x+, respectively (Fig. 3b). 

Phrase: "The logistic regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0681925:logistic regression analysis [Research Activity]
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0206031:Logistic Regression [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a highly statistically significant association between AD risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(P < 10-10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "of 1.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95% CI 1.3-1.5"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: "and"

Phrase: "2.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(95% CI 1.9-2.2"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: ")"

Phrase: "for genotypes xx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450371:XX [Organism Attribute]

Phrase: "and"

Phrase: "x+,"

Phrase: "respectively"

Phrase: "(Fig. 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.98: DISCUSSION In this paper we report an association between polymorphisms in the proximal region of the APOE promoter and risk for AD. 

Phrase: "DISCUSSION In this paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557061:Discussion [Therapeutic or Preventive Procedure]
   770   C2584313:Discussion [Social Behavior]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "an association between polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in the proximal region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the APOE promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.99: We have previously reported association of homozygosity for the -491A allele with risk for AD (7). 

Phrase: "We"

Phrase: "have"

Phrase: "previously reported association of homozygosity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "for the -491A allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "with risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for AD (7"

Phrase: ")."
Processing 00000000.tx.100: Here we show that the -427C allele is also associated with risk for AD. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the -427C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for AD."
Processing 00000000.tx.101: Furthermore, combination of these two alleles into the [-491A-427C] haplotype generates a high risk for AD, in particular in the Spanish population, in individuals bearing no ApoE4 alleles. 

Phrase: "Furthermore,"

Phrase: "combination of these two alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "into the [-491A-427C"

Phrase: "] haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "generates"

Phrase: "a high risk for AD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332167:High Risk [Qualitative Concept]
   806   C3272283:High Risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "in particular"

Phrase: "in the Spanish population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "no ApoE4 alleles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.102: The same effect is observed in the St Louis sample, although the relative risk was lower than in the Spanish sample. 

Phrase: "The same effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "observed in the St Louis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1441672:Observed [Functional Concept]
   760   C3272372:ST [Intellectual Product]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: ","

Phrase: "although"

Phrase: "the relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "in the Spanish sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.103: The difference in relative risk is most probably attributable to differences in the frequencies of APOE promoter haplotypes in the two control populations, since the two AD samples show very similar frequencies of promoter haplotypes. 

Phrase: "The difference in relative risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "is"

Phrase: "most probably attributable to differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596130:Attributable [Mental Process]

Phrase: "in the frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "of APOE promoter haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "in the two control populations,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   867   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "since"

Phrase: "the two AD samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "very similar frequencies of promoter haplotypes."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.104: It is well documented that population-based differences in ApoE4 allele frequency (9,10) give rise to population differences in relative risk for AD associated with this allele. 

Phrase: "It"

Phrase: "is"

Phrase: "well documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "that population-based differences in ApoE4 allele frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to population differences"

Phrase: "in relative risk"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Relative Risk [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "for AD"

Phrase: "associated with this allele."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0002085:Allele [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.105: Consistently, in our samples the OR associated with ApoE4 in the Spanish population (8.3) was more than double that in the St Louis sample (3.1) (7). 

Phrase: "Consistently,"

Phrase: "in our samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "the OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "associated with ApoE4"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the Spanish population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(8.3"

Phrase: ")"

Phrase: "was"

Phrase: "more than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205172:More [Functional Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "that in the St Louis sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   753   C3272372:ST [Intellectual Product]

Phrase: "(3.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.106: Based on these data, we anticipate that there will be wide variation in the relative risk for AD associated with the APOE promoter polymorphism in different populations, as has already been noted for the ApoE4 allele (11). 

Phrase: "Based on these data,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0242356:data base [Intellectual Product]
   802   C0993637:Data Base [Intellectual Product]
   770   C1511726:Data [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3245479:data [Medical Device]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "anticipate"

Phrase: "that there"

Phrase: "will"

Phrase: "be"

Phrase: "wide variation in the relative risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "for AD"

Phrase: "associated with the APOE promoter polymorphism"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1882417:Polymorphism [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in different populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "as"

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "noted for the ApoE4 allele"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C3642141:APOE*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C2984964:APOE4 [Laboratory Procedure]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.107: Dividing the sample on the basis of the presence or absence of ApoE4 revealed that the promoter polymorphisms and ApoE4 are independent risk factors. 

Phrase: "Dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the sample on the basis of the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0370003:Sample [Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "absence of ApoE4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the promoter polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "are"

Phrase: "independent risk factors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.108: Indeed, the risk due to the promoter polymorphism was most prominent in individuals without ApoE4 alleles. 

Phrase: "Indeed,"

Phrase: "the risk due to the promoter polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035647:Risk [Qualitative Concept]

Phrase: "was"

Phrase: "most prominent in individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205402:Prominent [Qualitative Concept]

Phrase: "without ApoE4 alleles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642141:APOE*4 Allele [Gene or Genome]
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.109: Table 3. 

Phrase: "Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.110: APOE [-491-427] major genotype distribution in ApoE [epsis]4 carriers and non-carriers; 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[-491-427"

Phrase: "] major genotype distribution in ApoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "[epsis"

Phrase: "]4 carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "non-carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007294:carriers [Finding]
   861   C1518422:Non [Functional Concept]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.111: age at onset >60 years ApoE4 status Spain (Madrid): n (f) USA (St Louis): n (f) [A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] [A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] -/- Cases 21 (0.54) 3 (0.08) 11 (0.29) 42 (0.57) 16 (0.21) 14 (0.19) Controls 52 (0.45) 45 (0.39) 9 (0.08) 67 (0.52) 35 (0.27) 15 (0.12) -/+, +/+ Cases 47 (0.66) 14 (0.20) 9 (0.13) 62 (0.71) 8 (0.09) 13 (0.14) Controls 10 (0.59) 5 (0.29) 1 (0.06) 29 (0.60) 7 (0.14) 8 (0.17) 2  2 [chi]2 test for [A-T]/[A-C] versus [A-T]/[T-T] in ApoE4 non-carriers: Spain, P = 0.00001; 

Phrase: "age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ">60 years ApoE4 status Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037747:Spain [Geographic Area]

Phrase: "(Madrid"

Phrase: ")"

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "(St Louis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: ")"

Phrase: ":"

Phrase: "n (f"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: "[A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] [A-T]/[A-T] [A-T]/[T-T] [A-T]/[A-C] -/- Cases 21"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   782   C0868928:Cases [Functional Concept]
   782   C1533148:Cases [Quantitative Concept]
   748 E C1706255:CASE [Medical Device]
   748 E C1706256:Case [Conceptual Entity]

Phrase: "(0.54"

Phrase: ")"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(0.08"

Phrase: ")"

Phrase: "11"

Phrase: "(0.29"

Phrase: ")"

Phrase: "42"

Phrase: "(0.57"

Phrase: ")"

Phrase: "16"

Phrase: "(0.21"

Phrase: ")"

Phrase: "14"

Phrase: "(0.19"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "52"

Phrase: "(0.45"

Phrase: ")"

Phrase: "45"

Phrase: "(0.39"

Phrase: ")"

Phrase: "9"

Phrase: "(0.08"

Phrase: ")"

Phrase: "67"

Phrase: "(0.52"

Phrase: ")"

Phrase: "35"

Phrase: "(0.27"

Phrase: ")"

Phrase: "15"

Phrase: "(0.12"

Phrase: ") -"

Phrase: "/+,"

Phrase: "+/+ Cases 47"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(0.66"

Phrase: ")"

Phrase: "14"

Phrase: "(0.20"

Phrase: ")"

Phrase: "9"

Phrase: "(0.13"

Phrase: ")"

Phrase: "62"

Phrase: "(0.71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "8"

Phrase: "(0.09"

Phrase: ")"

Phrase: "13"

Phrase: "(0.14"

Phrase: ")"

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "10"

Phrase: "(0.59"

Phrase: ")"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(0.29"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(0.06"

Phrase: ")"

Phrase: "29"

Phrase: "(0.60"

Phrase: ")"

Phrase: "7"

Phrase: "(0.14"

Phrase: ")"

Phrase: "8"

Phrase: "(0.17"

Phrase: ")"

Phrase: "2  2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[chi]2 test for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]

Phrase: "[A-T]/["
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "A-C]"

Phrase: "versus"

Phrase: "[A-T]/[T-T]"

Phrase: "in ApoE4 non-carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007294:carriers [Finding]
   827   C1518422:Non [Functional Concept]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: ":"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "P = 0.00001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.112: USA, P > 0.05 (not significant). 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "("

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.113: 2  2 [chi]2 test for [A-T]/[A-T] versus [A-T]/[T-T] in ApoE4 non-carriers: Spain, P = 0.0024; 

Phrase: "2  2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[chi]2 test for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]

Phrase: "[A-T]/[A-T]"

Phrase: "versus"

Phrase: "[A-T]/[T-T]"

Phrase: "in ApoE4 non-carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007294:carriers [Finding]
   827   C1518422:Non [Functional Concept]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: ":"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "P = 0.0024"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.114: USA, P > 0.05 (not significant). 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "P > 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "("

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.115: P-values for ApoE4 carriers were >0.05 (not significant) for both samples. 

Phrase: "P-values for ApoE4 carriers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1709380:P-Value [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: ">0.05"

Phrase: "("

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")"

Phrase: "for both samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.116: ApoE expression is regulated by complex interactions between developmental, hormonal and dietary factors (12-15). 

Phrase: "ApoE expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by complex interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439855:Complex [Qualitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737   C1704675:Interaction [Functional Concept]

Phrase: "between developmental, hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "dietary factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1511903:Dietary Factors [Functional Concept]
   861   C0012155:Dietary [Food]
   861   C2699635:DIETARY [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(12-15"

Phrase: ")."
Processing 00000000.tx.117: Regulation of APOE expression has been investigated thoroughly in hepatoma cells, where it has been shown that the elements required for efficient expression are located in the 5[prime] proximal region and in the first intron (16-18). 

Phrase: "Regulation of APOE expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "thoroughly in hepatoma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   799   C0677626:hepatoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0023903:Hepatoma [Neoplastic Process]
   770   C2239176:Hepatoma [Neoplastic Process]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "where"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "required for efficient expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0442799:Efficient [Qualitative Concept]
   770   C1514873:Required [Functional Concept]

Phrase: "are"

Phrase: "located in the 5"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] proximal region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and in the first intron"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "(16-18"

Phrase: ")."
Processing 00000000.tx.118: More recently, we have demonstrated that this region also drives efficient expression of APOE in astrocytoma cells (19). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "this region also"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "efficient expression of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in astrocytoma cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.119: The data presented in this report strongly suggest that allelic polymorphism in the transcriptional regulatory region of APOE may contribute to differences in the levels of ApoE synthesis by astrocytes. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented in this report strongly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0449450:Presented [Idea or Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that allelic polymorphism in the transcriptional regulatory region of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "contribute to differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1880177:Contribute [Activity]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of ApoE synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "by astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]
Processing 00000000.tx.120: Specifically, our data indicate that the single base substitutions corresponding to the -491 and -427 APOE polymorphic sites produce differences in transcriptional activity of the APOE promoter due to differential binding of nuclear proteins. 

Phrase: "Specifically,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the single base substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1555721:Substitution [Idea or Concept]
   793   C1706204:Substitution [Activity]

Phrase: "corresponding to the -491"

Phrase: "and -"

Phrase: "427 APOE polymorphic sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "produce"

Phrase: "differences in transcriptional activity of the APOE promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "due to differential binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "of nuclear proteins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]
Processing 00000000.tx.121: It is well documented that single nucleotide changes within a promoter region can dramatically affect transcriptional activity mediated by transcription factors (20-22). 

Phrase: "It"

Phrase: "is"

Phrase: "well documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "that single nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "changes within a promoter region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017446:Region [Geographic Area]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205147:Region [Spatial Concept]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "dramatically"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "mediated by transcription factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0040649:Transcription [Genetic Function]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(20-22"

Phrase: ")."
Processing 00000000.tx.122: The data presented here strongly suggest the existence of a direct correlation between risk for AD and APOE promoter activity in astrocytic cells, i.e. the higher the expression of ApoE, the higher the risk for AD. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here strongly"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of a direct correlation"

Phrase: "between risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for AD"

Phrase: "and"

Phrase: "APOE promoter activity in astrocytic cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "the expression of ApoE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "the risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.123: There is increasing evidence suggesting that increased levels of ApoE are associated with AD pathogenesis. 

Phrase: "There"

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that increased levels of ApoE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "associated with AD pathogenesis."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.124: Several studies have reported that ApoE levels are elevated in the brain and in plasma from AD patients (23-25). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ApoE levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "elevated in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205250:Elevated [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "and in plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032105:Plasma [Body Substance]
   790   C1515981:And [Idea or Concept]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(23-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: Intracellular accumulation of ApoE has also been correlated with neuronal cell death and intracellular A[beta] stabilization (26). 

Phrase: "Intracellular accumulation of ApoE"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "correlated with neuronal cell death"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1707520:Correlated [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "intracellular A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "] stabilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.126: Recent studies have also demonstrated that the level of ApoE expression can modify both the cytotoxic effects of ApoE and the propensity of A[beta] to deposit in the murine brain. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the level of ApoE expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3244092:expression level [Idea or Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "both the cytotoxic effects of ApoE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1280500:effects [Qualitative Concept]
   753   C1511636:cytotoxic [Functional Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the propensity of A[beta"

Phrase: "] to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deposit in the murine brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0026809:Murine [Mammal]
   760   C0333562:Deposit [Functional Concept]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.127: ApoE at concentrations found in the cerebrospinal fluid protects neuronal cells from A[beta] peptides, while higher ApoE concentrations could lead to neuronal cell death (27). 

Phrase: "ApoE at concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "found in the cerebrospinal fluid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0007806:Cerebrospinal Fluid [Body Substance]
   806   C0007807:cerebrospinal fluid [Functional Concept]
   760   C0005889:FLUID [Body Substance]
   760   C0150312:Found [Quantitative Concept]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   726 E C0243095:Find [Finding]

Phrase: "protects"

Phrase: "neuronal cells from A[beta"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0030281:Beta cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "] peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "while"

Phrase: "higher ApoE concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "could"

Phrase: "lead to neuronal cell death"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   862   C2754100:neuronal cell death [Cell Function]
           neuron death
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.128: Crossing APOE knockout mice with mice overexpressing a human mutant APP gene indicates that A[beta] deposition correlates positively with ApoE dose and suggests that ApoE may facilitate A[beta] peptide deposition in vivo (28). 

Phrase: "Crossing APOE knockout mice with mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C0025914:mouse, mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "a human mutant APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0314604:Human gene [Gene or Genome]
   876   C0678941:mutant gene [Gene or Genome]
   827   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017337:Gene [Gene or Genome]
   709   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "indicates"

Phrase: "that A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "] deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "correlates"

Phrase: "positively with ApoE dose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0178602:Dose [Quantitative Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   770   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "facilitate"

Phrase: "A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "] peptide deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.129: Despite the evidence implicating ApoE4 as the single most important genetic determinant of susceptibility to late onset AD, its pathogenic role is not well understood. 

Phrase: "Despite the evidence implicating ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   827   C2984964:APOE4 [Laboratory Procedure]

Phrase: "as the single most important genetic determinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1521761:Determinant [Functional Concept]

Phrase: "of susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to late onset AD,"

Phrase: "its pathogenic role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "not well understood."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   793   C0162340:Understand [Mental Process]
Processing 00000000.tx.130: The amino acid substitutions associated with the E2, E3 and E4 ApoE isoforms lead to differences in the predicted three-dimensional structure of ApoE that are likely to alter the functional properties of the molecule. 

Phrase: "The amino acid substitutions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   793   C1555721:Substitution [Idea or Concept]
   793   C1706204:Substitution [Activity]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "associated with the E2,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C3539520:E2 [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4 ApoE isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "lead to differences"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in the predicted three-dimensional structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0450363:3-Dimensional [Spatial Concept]
   812   C0205449:Three [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "of ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the functional properties of the molecule."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.131: Several potential mechanisms of action of ApoE4 on AD risk have been proposed, based on the ApoE isoform-specific differences observed in several assays developed in brain cells (28-35). 

Phrase: "Several potential mechanisms of action of ApoE4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0031327:mechanism of action [Physiologic Function]
   802   C1524059:mechanism of action [Functional Concept]
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "on AD risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: ","

Phrase: "based on the ApoE isoform-specific differences"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205369:Specific [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C1412481:APOE [Gene or Genome]
   748   C1527178:Based [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "observed in several assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "developed in brain cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0596208:brain cells [Cell]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0007634:Cells [Cell]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(28-35"

Phrase: ")."
Processing 00000000.tx.132: However, to date there is no adequate explanation for the variation in risk for AD associated with the different ApoE isoforms. 

Phrase: "However,"

Phrase: "to date there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "is"

Phrase: "no adequate explanation for the variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "for AD"

Phrase: "associated with the different ApoE isoforms."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0523511:APOE [Laboratory Procedure]
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   753   C1412481:APOE [Gene or Genome]
   753   C1705242:Different [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.133: Based upon data presented here and elsewhere we suggest that there are two independent mechanisms by which AD risk can be modified in the APOE gene. 

Phrase: "Based upon data"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   841   C0242356:data base [Intellectual Product]
   841   C0993637:Data Base [Intellectual Product]
   790   C1511726:Data [Idea or Concept]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C3245479:data [Medical Device]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "and"

Phrase: "elsewhere"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "two independent mechanisms by which AD risk"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "modified in the APOE gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1412481:APOE gene [Gene or Genome]
           APOE
   797   C1517476:Gene-Modified [Qualitative Concept]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0392747:Modified [Functional Concept]
   760   C0523511:APOE [Laboratory Procedure]
Processing 00000000.tx.134: The first involves variants in the coding region that alter the functional properties of the ApoE molecule, while the second involves promoter region variants that result in quantitative differences in ApoE expression. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "involves"

Phrase: "variants in the coding region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the functional properties of the ApoE molecule,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "while"

Phrase: "the second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "involves"

Phrase: "promoter region variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:variants [Qualitative Concept]
   734   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "result in quantitative differences"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C1709795:Quantitative Result [Finding]
   770   C0392762:Quantitative [Quantitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in ApoE expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.135: These two factors are associated with AD risk independently, i.e. each one can produce risk by itself, but may interact with each other resulting in an overall risk for individuals bearing both ApoE4 and high expressing APOE promoter forms that would depend on the relative contribution of each of these two risk factors. 

Phrase: "These two factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "independently,"

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "each one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "can"

Phrase: "produce"

Phrase: "risk by itself,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "interact with each other"

Phrase: "resulting in an overall risk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0332294:Resulting in [Functional Concept]
   760   C0035647:Risk [Qualitative Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C0678226:resulting [Functional Concept]
   760   C1561607:Overall [Qualitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "for individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "both ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "high expressing APOE promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "would"

Phrase: "depend on the relative contribution of each of these two risk factors."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0035648:risk factors [Quantitative Concept]
   753   C1553898:risk factors [Idea or Concept]
   751   C0242492:Relative Risk [Quantitative Concept]
   736   C0035647:Risk [Qualitative Concept]
   736   C0080103:Relative [Family Group]
   736   C0205345:Relative [Qualitative Concept]
   736   C0205448:Two [Quantitative Concept]
   736   C0725813:depend [Medical Device]
   736   C1547039:*Relative [Quantitative Concept]
   736   C1880177:Contribution [Activity]
   703   C1521761:Factor [Functional Concept]
   703   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.136: In summary, our data strongly suggest that risk for AD associated with APOE promoter polymorphisms directly correlates with the transcriptional activity of the gene. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that risk for AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "associated with APOE promoter polymorphisms directly"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1947931:Directly [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "correlates with the transcriptional activity of the gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0017337:Gene [Gene or Genome]
   744   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.137: Further, we speculate that increases in the local expression of ApoE, due to the APOE promoter polymorphisms, could lead to enhanced deposition of A[beta] peptide in the brain, thus explaining the increased risk for AD. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "speculate"

Phrase: "that increases in the local expression of ApoE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "due to the APOE promoter polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "could"

Phrase: "lead to enhanced deposition of A[beta"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0333605:Deposition of lead [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0330390:Beta [Plant]
   748   C0333562:Deposition [Functional Concept]
   748   C0439096:Beta [Intellectual Product]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2004068:Beta [Qualitative Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C2349975:Enhanced [Activity]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "] peptide in the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "thus"

Phrase: "explaining"

Phrase: "the increased risk for AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
Processing 00000000.tx.138: If this is correct, then drugs that either control ApoE synthesis or inhibit A[beta] production or deposition may be useful in the treatment of AD. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "correct, then drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that either control ApoE synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "or"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "] production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "or"

Phrase: "deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "useful in the treatment of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1524063:Use of [Functional Concept]
Processing 00000000.tx.139: MATERIALS AND METHODS Study subjects The test sample consisted of 132 healthy controls (age of onset 72  7 years, mean  SD) and 110 late onset sporadic AD cases (68  5 years) from the Madrid region of Spain, recruited from the Neurology Service of the Hospital La Paz of Madrid. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "The test sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "consisted of 132 healthy controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2986479:Healthy Control [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(age of onset 72  7 years,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C1510829:Age-Years [Temporal Concept]
   753   C0001779:Age [Organism Attribute]

Phrase: "mean  SD)"

Phrase: "and"

Phrase: "110 late onset sporadic AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "(68  5 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "from the Madrid region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "recruited from the Neurology Service of the Hospital La Paz of Madrid."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0587591:Neurology service [Therapeutic or Preventive Procedure]
   751   C1550360:Hospital Service [Health Care Related Organization]
   736   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   736   C0023031:La [Element, Ion, or Isotope]
   736   C0027855:Neurology [Biomedical Occupation or Discipline]
   736   C0557854:Service [Occupational Activity]
   736   C1510665:Hospital [Qualitative Concept]
   736   C2825316:Service [Manufactured Object]
   736   C3245478:service [Idea or Concept]
Processing 00000000.tx.140: The replication sample was composed of 175 healthy controls (78  9 years) and 160 AD (36,37) cases (75  8 years) from the St Louis metropolitan region of the USA, recruited through the Alzheimer's Disease Research Center at Washington University. 

Phrase: "The replication sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "composed of 175 healthy controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2986479:Healthy Control [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(78  9 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "160 AD (36,"

Phrase: "37"

Phrase: ")"

Phrase: "cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "(75  8 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "from the St Louis metropolitan region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0599587:metropolitan [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of the USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "recruited through the Alzheimer's Disease Research Center"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0683939:research center [Manufactured Object,Organization]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0035168:research [Research Activity]
   748   C0205099:Center [Spatial Concept]
   748   C0242481:Research [Research Activity]

Phrase: "at Washington University."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0043038:Washington [Geographic Area]
Processing 00000000.tx.141: Both samples included only individuals of Caucasian origin. 

Phrase: "Both samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only individuals of Caucasian origin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]
Processing 00000000.tx.142: Genotyping of -491A/T, -427T/C and ApoE polymorphisms The APOE region -512 to -285 was amplified by nested PCR using a mismatched primer to generate a DraI site specific for the -491A allele. 

Phrase: "Genotyping of -491A/T, -"

Phrase: "427T/C"

Phrase: "and"

Phrase: "ApoE polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "The APOE region -512 to -285"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "was"

Phrase: "amplified by nested PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242574:Nested PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mismatched primer to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "generate"

Phrase: "a DraI"

Phrase: "site specific for the -491A allele."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0449604:site specific [Spatial Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1552740:specific [Intellectual Product]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.143: Briefly, PCR was used to amplify a 1423 bp fragment of the transcriptional regulatory region, spanning -1017 to +406 relative to the transcriptional start site (16). 

Phrase: "Briefly,"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "a 1423 bp fragment of the transcriptional regulatory region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "spanning -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "1017 to +406 relative to the transcriptional start site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.144: Primers 5[prime]-CAAGGTCACACAGCTGGCAAC-3[prime] and 5[prime]-TCCAATCGACGGCTAGCTACC-3[prime] were used to amplify the whole transcriptional regulatory region. 

Phrase: "Primers 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-CAAGGTCACACAGCTGGCAAC-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TCCAATCGACGGCTAGCTACC-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the whole transcriptional regulatory region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.145: A nested PCR was used because we had difficulty in reliably amplifying the -512 to -285 fragment directly from genomic DNA. 

Phrase: "A nested PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242574:Nested PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "we"

Phrase: "had"

Phrase: "difficulty in reliably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1299586:Difficulty [Finding]
   718 E C0332218:Difficult [Qualitative Concept]

Phrase: "amplifying"

Phrase: "the -512 to -285 fragment directly from genomic DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.146: The 1423 bp PCR product was therefore used as template in the following reaction. 

Phrase: "The 1423 bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "therefore"

Phrase: "used as template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0728990:TEMPLATE [Medical Device]
   790   C1273517:used [Finding]
   790   C1514575:Template [Conceptual Entity]
   790   C1705542:Template [Idea or Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in the following reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.147: The forward (mismatched) primer was 5[prime]-TGTTGGCCAGGCTGGTTTTAA-3[prime], the reverse primer 5[prime]-CCTCCTTTCCTGACCCTGTCC-3[prime]. 

Phrase: "The forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "(mismatched"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881865:Mismatch [Qualitative Concept]

Phrase: ")"

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TGTTGGCCAGGCTGGTTTTAA-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "],"

Phrase: "the reverse primer 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-CCTCCTTTCCTGACCCTGTCC-3"

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]."
Processing 00000000.tx.148: To analyze the -491 and-427 genotypes, as well as the [-491-427] haplotype, the product was digested with DraI and AluI restriction enzymes together. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the -491"

Phrase: "and-"

Phrase: "427 genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "as well as"

Phrase: "the [-491-427"

Phrase: "] haplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "the product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with DraI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "AluI restriction enzymes together."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   812   C0443288:Restriction [Functional Concept]
Processing 00000000.tx.149: ApoE isoform genotyping was performed as described (38,39). 

Phrase: "ApoE isoform genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.150: Transfection assays The 5[prime] region between positions -1017 and +406 of the APOE gene was cloned into the pXP2-luciferase reporter plasmid as described (19). 

Phrase: "Transfection assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "The 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "] region between positions -1017"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "and +"

Phrase: "406 of the APOE gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1412481:APOE gene [Gene or Genome]
           APOE
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0523511:APOE [Laboratory Procedure]

Phrase: "was"

Phrase: "cloned into the pXP2-luciferase reporter plasmid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0009013:cloned [Cell]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]
   714 E C1522642:Clone [Tissue]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.151: PCR-based site-directed mutagenesis was used to replace the A by a T at -491 and the T by a C at -427 using a modification of a described method (40). 

Phrase: "PCR-based site-directed mutagenesis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   884   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   804   C0079866:Mutagenesis [Molecular Function]
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   804   C3146302:Mutagenesis [Laboratory Procedure]
   771   C0439851:Direct [Qualitative Concept]
   771   C1947931:Direct [Qualitative Concept]
   733 E C0439755:Directions [Spatial Concept]
   733 E C0449738:Direction [Spatial Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "the A by a T at -491"

Phrase: "and"

Phrase: "the T by a C at -427"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of a described method"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.152: The constructs were transfected into U87 human astrocytoma cells and luciferase and [beta]-galactosidase activities of the extracts were determined as described (19). 

Phrase: "The constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "transfected into U87 human astrocytoma cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0004114:Astrocytoma [Neoplastic Process]
   753   C0007634:Cells [Cell]
   753   C0086418:Human [Human]
   753   C1822629:U87 [Gene or Genome]
   753   C1822997:U87 [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and ["

Phrase: "beta]-galactosidase activities of the extracts"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C1150053:beta-galactosidase activity [Molecular Function]
   773   C1150051:galactosidase activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.153: Electrophoretic mobility shift assays (EMSA) EMSA of oligonucleotide probes by U87 nuclear extracts was performed as described (5,7). 

Phrase: "Electrophoretic mobility shift assays (EMSA) EMSA of oligonucleotide probes"

Phrase: "by U87 nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   793   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.154: The oligonucleotides 5[prime]-GCTGGTCTCAA(A/T)CTCCTGACCTTAA-3[prime] and 5[prime]-ACAGGCGTGAGC(T/C)ACCGCCCCCAGC-3[prime] were used to study nuclear protein binding to the -491 and -427 sites, respectively. 

Phrase: "The oligonucleotides 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-GCTGGTCTCAA"

Phrase: "(A/T)CTCCTGACCTTAA-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-ACAGGCGTGAGC"

Phrase: "(T/C)ACCGCCCCCAGC-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0041014:T-3 [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2603360:T' [Clinical Attribute]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "nuclear protein binding to the -491"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0033618:Protein Binding [Molecular Function]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and -"

Phrase: "427 sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.155: Statistical analysis Genotype and allele/haplotype distributions were analyzed by 2  2 [chi]2 test. 

Phrase: "Statistical analysis Genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "and"

Phrase: "allele/haplotype distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037775:Distributions [Spatial Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "analyzed by 2  2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "[chi]2 test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.156: Relative risks (ORs) and 95% CIs were calculated as described (41). 

Phrase: "Relative risks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242492:Risks, Relative [Quantitative Concept]
   861   C0035647:Risks [Qualitative Concept]
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "(ORs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "95% CIs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1504308:Cis [Eukaryote]

Phrase: "were"

Phrase: "calculated as described"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   790   C1552738:described [Idea or Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.157: A logistic regression model was used to estimate relative risks for AD of the major APOE promoter genotypes as a function of the transcriptional activity. 

Phrase: "A logistic regression model"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0023965:Logistic Model [Intellectual Product,Quantitative Concept]
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "relative risks for AD of the major APOE promoter genotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0242492:Risks, Relative [Quantitative Concept]
   739   C0035647:Risks [Qualitative Concept]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of the transcriptional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.158: ACKNOWLEDGEMENTS We thank P. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.159: Alonso of the Hospital Ramn y Cajal of Madrid for her kind collaboration in sample collection, P. 

Phrase: "Alonso of the Hospital Ramn y Cajal of Madrid"

Phrase: "for her kind collaboration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282116:Collaboration [Social Behavior]

Phrase: "in sample collection,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0200345:sample collection [Laboratory Procedure]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.160: Barreiro-Tella and E. 

Phrase: "Barreiro-Tella"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.161: Dez-Tejedor of the Hospital La Paz of Madrid for advice on clinical work and the faculty and staff of the Washington University Alzheimer's Disease Research Center for patient evaluation and sample collection. 

Phrase: "Dez-Tejedor of the Hospital La Paz of Madrid"

Phrase: "for advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150600:Advice [Health Care Activity]

Phrase: "on clinical work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "the faculty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015535:Faculty [Professional or Occupational Group]

Phrase: "and"

Phrase: "staff of the Washington University Alzheimer's Disease Research Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851286:Staff [Professional or Occupational Group]
   742   C1947908:Staff [Professional or Occupational Group]

Phrase: "for patient evaluation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0679830:patient evaluation [Health Care Activity]
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "sample collection."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0200345:sample collection [Laboratory Procedure]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]
Processing 00000000.tx.162: We thank J. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.163: Baty of the Washington University Division of Biostatistics for advice on statistical analysis. 

Phrase: "Baty of the Washington University Division of Biostatistics"

Phrase: "for advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150600:Advice [Health Care Activity]

Phrase: "on statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.164: We thank F. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.165: Mayor for his continuous encouragement and help. 

Phrase: "Mayor for his continuous encouragement"

Phrase: "and"

Phrase: "help."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]
Processing 00000000.tx.166: We thank the patients and healthy individuals who participated in this research. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "healthy individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "who"

Phrase: "participated in this research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
Processing 00000000.tx.167: This work was supported by Boehringer Ingelheim Espaa, Fondo de Investigacin Sanitaria (grant no. 95-0022), NIH (AG05681 and AG03991), the Alzheimer's Association, the Nettie and Rebecca Brown Foundation and the Metropolitan Life Foundation. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Boehringer Ingelheim Espaa,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0331792:Boehringer Ingelheim [Health Care Related Organization]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "Fondo de Investigacin Sanitaria"

Phrase: "(grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "no. 95-0022"

Phrase: ")"

Phrase: ","

Phrase: "NIH (AG05681"

Phrase: "and"

Phrase: "AG03991"

Phrase: ")"

Phrase: ","

Phrase: "the Alzheimer's Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "the Nettie"

Phrase: "and"

Phrase: "Rebecca Brown Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Metropolitan Life Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.168: The institutional grant from the Fundacin Ramn Areces to CBMSO is acknowledged. 

Phrase: "The institutional grant from the Fundacin Ramn Areces"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018173:Grant [Quantitative Concept]
   744   C1548284:Grant [Idea or Concept]

Phrase: "to CBMSO"

Phrase: "is"

Phrase: "acknowledged."
Processing 00000000.tx.169: M.J.A. is the recipient of a fellowship from the Fondo de Investigacin Sanitaria. 

Phrase: "M."

Phrase: "J."

Phrase: "A."

Phrase: "is"

Phrase: "the recipient of a fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "from the Fondo de Investigacin Sanitaria."
Processing 00000000.tx.170: M.A.G. is the recipient of a fellowship from the Spanish Ministerio de Educacin y Ciencia. 

Phrase: "M.A.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0456715:m g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "is"

Phrase: "the recipient of a fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "from the Spanish Ministerio de Educacin y Ciencia."
Processing 00000000.tx.171: C.L.L. is a post-doctoral fellow of the Washington University Alzheimer's Disease Research Center. 

Phrase: "C.L.L."

Phrase: "is"

Phrase: "a post-doctoral fellow of the Washington University Alzheimer's Disease Research Center."
Processing 00000000.tx.172: A.M.G. is the recipient of an NIH career development award (AG00634). 

Phrase: "A.M.G."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456715:m g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]
   734   C2346751:A/m [Quantitative Concept]

Phrase: "is"

Phrase: "the recipient of an NIH career development award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709854:Recipient [Human]

Phrase: "(AG00634"

Phrase: ")."
Processing 00000000.tx.173: ABBREVIATIONS AD, Alzheimer's disease; 

Phrase: "ABBREVIATIONS AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.174: ApoE, apolipoprotein E; 

Phrase: "ApoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.175: APOE, apolipoprotein E gene; 

Phrase: "APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.176: APP, [beta]-amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "[beta]-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.177: CI, confidence interval; 

Phrase: "CI,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.178: OR, odds ratio. 

Phrase: "OR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "odds ratio."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.179: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.180: Goate, A., Chartier-Harlin, M.C., Mullan, M. et al). 

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M. et al"

Phrase: ")."
Processing 00000000.tx.181: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.182: Nature, 349, 704-709. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704-709."
Processing 00000000.tx.183: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.184: Sherrington, R., Rogaev, E., Liang, Y. et al.) 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y. et al."

Phrase: ")"
Processing 00000000.tx.185: (1995) Cloning a gene bearing missense mutations in early-onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]
   966 E C0009013:Clone [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "a gene bearing missense mutations in early-onset familial Alzheimer's disease."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0599155:Mutations, Missense [Genetic Function]
   754   C0596611:gene mutations [Genetic Function]
   738   C0026882:Mutations [Genetic Function]
   704 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.186: Nature, 375, 754-760. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754-760."
Processing 00000000.tx.187: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.188: Levy-Lahad, E., Wasco, W., Poorkaj, P. et al.) 

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P. et al."

Phrase: ")"
Processing 00000000.tx.189: (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Candidate gene for the chromosome 1 familial Alzheimer's disease locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   757   C1708726:Gene Locus [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   730   C1416989:MAL gene [Gene or Genome]
   722   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.190: Science, 269, 973-977. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "973-977."
Processing 00000000.tx.191: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.192: Corder, E.H., Saunders, A.M., Strittmatter, W.J. et al.) 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J. et al."

Phrase: ")"
Processing 00000000.tx.193: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of AD in late onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.194: Science, 261, 921-923. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."
Processing 00000000.tx.195: MEDLINE Abstract 5. 

Phrase: "MEDLINE Abstract 5."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.196: Artiga, M.J., Bullido, M.J., Sastre, I. et al.) 

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Sastre,"

Phrase: "I. et al."

Phrase: ")"
Processing 00000000.tx.197: (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C0678951:gene polymorphisms [Genetic Function]
   738   C0032529:polymorphisms [Genetic Function]
   704 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.198: FEBS Lett., 421, 105-108. 

Phrase: "FEBS Lett.,"

Phrase: "421,"

Phrase: "105-108."
Processing 00000000.tx.199: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.200: Mui, S., Briggs, M., Chung, H. et al.) 

Phrase: "Mui,"

Phrase: "S."

Phrase: ","

Phrase: "Briggs,"

Phrase: "M."

Phrase: ","

Phrase: "Chung,"

Phrase: "H. et al."

Phrase: ")"
Processing 00000000.tx.201: (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the [epsis]4 allele. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A newly identified polymorphism in the apolipoprotein E enhancer gene region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "strongly with the [epsis"

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.202: Neurology, 47, 196-201. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "196-201."
Processing 00000000.tx.203: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.204: Bullido, M.J., Artiga, M.J., Recuero, M. et al.) 

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Recuero,"

Phrase: "M. et al."

Phrase: ")"
Processing 00000000.tx.205: (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A polymorphism in the regulatory region of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0035647:Risk [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for Alzheimer's dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.206: Nature Genet., 18, 69-71. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "69-71."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450388:69 [Intellectual Product]
   861   C0450389:71 [Intellectual Product]
Processing 00000000.tx.207: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.208: Lambert, J.C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin, M.C. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cottel,"

Phrase: "D."

Phrase: ","

Phrase: "Frigard,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Amouyel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Chartier-Harlin,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.209: (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A new polymorphism in the APOE promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with risk of developing Alzheimer's dementia."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Dementia [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0035647:Risk [Qualitative Concept]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.210: Hum. 

Phrase: "Hum."
Processing 00000000.tx.211: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.212: Genet., 7, 533-540. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "533-540."
Processing 00000000.tx.213: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.214: Gerdes, U.L., Klausen, I.C., Sihm, I. and Faergeman, O. 

Phrase: "Gerdes,"

Phrase: "U.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439339:U/L [Quantitative Concept]

Phrase: "Klausen,"

Phrase: "I.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sihm,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Faergeman,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.215: (1992) Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism in a Danish population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "compared to findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1707455:Compared [Activity]
   790   C2607943:findings [Functional Concept]
   790   C2926606:Findings [Clinical Attribute]
   790   C3539655:Findings [Intellectual Product]
   756 E C0037088:Finding [Sign or Symptom]
   756 E C0243095:Finding [Finding]
   756 E C2825141:Finding [Finding]

Phrase: "in 45"

Phrase: "other study populations around the world."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0681876:Population Study [Research Activity]
   756 E C2348561:Study Population [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C1257890:Population [Population Group]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.216: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.217: Epidemiol., 9, 155-167. 

Phrase: "Epidemiol.,"

Phrase: "9,"

Phrase: "155-167."
Processing 00000000.tx.218: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.219: Lucotte, G., Loirat, F. and Hazout, S. 

Phrase: "Lucotte,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Loirat,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hazout,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.220: (1997) Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Pattern of gradient of apolipoprotein E allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0449774:Pattern [Spatial Concept]
   748   C0812409:Gradient [Quantitative Concept]

Phrase: "*4 frequencies in western Europe."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.221: Hum. 

Phrase: "Hum."
Processing 00000000.tx.222: Biol., 69, 253-262. 

Phrase: "Biol.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "253-262."
Processing 00000000.tx.223: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.224: Farrer, L.A., Cupples, L.A., Haines, J.L. et al.) 

Phrase: "Farrer,"

Phrase: "L.A.,"

Phrase: "Cupples,"

Phrase: "L.A.,"

Phrase: "Haines,"

Phrase: "J.L. et al."

Phrase: ")"
Processing 00000000.tx.225: (1997) Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.226: A meta-analysis. 

Phrase: "A meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.227: APOE and Alzheimer Disease Meta Analysis Consortium. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer Disease Meta Analysis Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1513822:Consortium [Professional or Occupational Group]
   804   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.228: J. 

Phrase: "J."
Processing 00000000.tx.229: Am. 

Phrase: "Am."
Processing 00000000.tx.230: Med. 

Phrase: "Med."
Processing 00000000.tx.231: Assoc., 278, 1349-1356. 

Phrase: "Assoc.,"

Phrase: "278,"

Phrase: "1349-1356."
Processing 00000000.tx.232: 12. 

Phrase: "12."
Processing 00000000.tx.233: Lin-Lee, Y.C., Tanaka, Y., Lin, C.T. and Chan, L. 

Phrase: "Lin-Lee,"

Phrase: "Y.C., Tanaka,"

Phrase: "Y.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chan,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.234: (1981) Effects of an atherogenic diet on apolipoprotein E biosynthesis in the rat. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Effects of an atherogenic diet"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on apolipoprotein E biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.235: Biochemistry, 20, 6474-6480. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "20,"

Phrase: "6474-6480."
Processing 00000000.tx.236: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.237: Reue, K.L., Quon, D.H., O'Donnell, K.A., Dizikes, G.J., Fareed, G.C. and Lusis, A.J. 

Phrase: "Reue,"

Phrase: "K.L., Quon,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "O'Donnell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dizikes,"

Phrase: "G.J.,"

Phrase: "Fareed,"

Phrase: "G.C."

Phrase: "and"

Phrase: "Lusis,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.238: (1984) Cloning and regulation of messenger RNA for mouse apolipoprotein E. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "regulation of messenger RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "for mouse apolipoprotein E."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.239: J. 

Phrase: "J."
Processing 00000000.tx.240: Biol. 

Phrase: "Biol."
Processing 00000000.tx.241: Chem., 259, 2100-2107. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "259,"

Phrase: "2100-2107."
Processing 00000000.tx.242: MEDLINE Abstract 14. 

Phrase: "MEDLINE Abstract 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.243: Elshourbagy, N.A., Liao, W.S., Mahley, R.W. and Taylor, J.M. 

Phrase: "Elshourbagy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Liao,"

Phrase: "W.S.,"

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.244: (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver and is present in other peripheral tissues of rats and marmosets. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Apolipoprotein E mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "abundant in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "adrenals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "as well as in the liver"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "is"

Phrase: "present in other peripheral tissues of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "marmosets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006764:Marmosets [Mammal]
Processing 00000000.tx.245: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.246: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.247: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.248: USA, 82, 203-207. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "82,"

Phrase: "203-207."
Processing 00000000.tx.249: MEDLINE Abstract 15. 

Phrase: "MEDLINE Abstract 15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.250: Kayden, H.J., Maschio, F. and Traber, M.G. 

Phrase: "Kayden,"

Phrase: "H.J.,"

Phrase: "Maschio,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Traber,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.251: (1985) The secretion of apolipoprotein E by human monocyte-derived macrophages. 

Phrase: "(1985"

Phrase: ")"

Phrase: "The secretion of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "by human monocyte-derived macrophages."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0024432:Monocyte-Derived Macrophages [Cell]
           Macrophages
   812   C0026473:Monocyte [Cell]
   812   C0086418:Human [Human]
   812   C1441547:Derived [Qualitative Concept]
   812   C1546706:Macrophages [Intellectual Product]
   812   C1550652:Macrophages [Body Substance]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.252: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.253: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.254: Biophys., 239, 388-395. 

Phrase: "Biophys.,"

Phrase: "239,"

Phrase: "388-395."
Processing 00000000.tx.255: MEDLINE Abstract 16. 

Phrase: "MEDLINE Abstract 16."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.256: Paik, Y.K., Chang, D.J., Reardon, C.A., Walker, M.D., Taxman, E. and Taylor, J.M. 

Phrase: "Paik,"

Phrase: "Y.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chang,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reardon,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Taxman,"

Phrase: "E."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: (1988) Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of transcriptional regulatory regions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "associated with expression of the human apolipoprotein E gene."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C1412481:Apolipoprotein E gene [Gene or Genome]
   764   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0017262:Gene Expression [Genetic Function]
   762   C0314604:Human gene [Gene or Genome]
   762   C1445865:Apolipoprotein gene [Gene or Genome]
   742   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0017337:Gene [Gene or Genome]
   742   C0086418:Human [Human]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.258: J. 

Phrase: "J."
Processing 00000000.tx.259: Biol. 

Phrase: "Biol."
Processing 00000000.tx.260: Chem., 263, 13340-13349. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "263,"

Phrase: "13340-13349."
Processing 00000000.tx.261: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.262: Smith, J.D., Melin, A., Leff, T. and Breslow, J.L. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Melin,"

Phrase: "A.,"

Phrase: "Leff,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "J.L."
Processing 00000000.tx.263: (1988) Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Expression of the human apolipoprotein E gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by multiple positive"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0439178:% Positive [Quantitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.264: J. 

Phrase: "J."
Processing 00000000.tx.265: Biol. 

Phrase: "Biol."
Processing 00000000.tx.266: Chem., 263, 8300-8308. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "263,"

Phrase: "8300-8308."
Processing 00000000.tx.267: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.268: Berg, D.T., Calnek, D.S. and Grinnell, B.W. 

Phrase: "Berg,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Calnek,"

Phrase: "D.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Grinnell,"

Phrase: "B.W."
Processing 00000000.tx.269: (1995) The human apolipoprotein E gene is negatively regulated in human liver HepG2 cells by the transcription factor BEF-1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The human apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1412481:Apolipoprotein E gene [Gene or Genome]
   902   C0314604:Human gene [Gene or Genome]
   875   C1445865:Apolipoprotein gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "negatively"

Phrase: "regulated in human liver HepG2 cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C2717940:HepG2 Cells [Cell]
   783   C0227525:liver cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "by the transcription factor BEF-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1425988:BEF [Gene or Genome]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.270: J. 

Phrase: "J."
Processing 00000000.tx.271: Biol. 

Phrase: "Biol."
Processing 00000000.tx.272: Chem., 270, 15447-15450. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "15447-15450."
Processing 00000000.tx.273: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.274: Garca, M.A., Vzquez, J., Gimnez, C., Valdivieso, F. and Zafra, F. 

Phrase: "Garca,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vzquez,"

Phrase: "J.,"

Phrase: "Gimnez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Valdivieso,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Zafra,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.275: (1996) Transcriptional factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Transcriptional factor AP-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   982   C0059296:Transcription Factor AP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   899   C0126037:Transcription Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   899   C1420636:TRANSCRIPTION FACTOR 2 [Gene or Genome]

Phrase: "regulates"

Phrase: "human apolipoprotein E gene expression in astrocytoma cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1412481:Apolipoprotein E gene [Gene or Genome]
   770   C0017262:Gene Expression [Genetic Function]
   767   C0314604:Human gene [Gene or Genome]
   767   C1445865:Apolipoprotein gene [Gene or Genome]
   750   C1861886:CELL Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.276: J. 

Phrase: "J."
Processing 00000000.tx.277: Neurosci., 16, 7550-7556. 

Phrase: "Neurosci.,"

Phrase: "16,"

Phrase: "7550-7556."
Processing 00000000.tx.278: MEDLINE Abstract 20. 

Phrase: "MEDLINE Abstract 20."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.279: Sloan, J.H., Hasegawa, S.L. and Boss, J.M. 

Phrase: "Sloan,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Boss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265514:BOS [Disease or Syndrome]
  1000   C1265540:Bos [Mammal]

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: (1992) Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Single base pair substitutions within the HLA-DRA gene promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1555721:Substitution [Idea or Concept]
   706   C1706204:Substitution [Activity]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "the functions of the X1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "X2 boxes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]
Processing 00000000.tx.281: J. 

Phrase: "J."
Processing 00000000.tx.282: Immunol., 148, 2591-2599. 

Phrase: "Immunol.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: "148,"

Phrase: "2591-2599."
Processing 00000000.tx.283: MEDLINE Abstract 21. 

Phrase: "MEDLINE Abstract 21."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.284: Angotti, E., Mele, E., Costanzo, F. and Avvedimento, E.V. 

Phrase: "Angotti,"

Phrase: "E.,"

Phrase: "Mele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999548:mele [Mammal]

Phrase: "E.,"

Phrase: "Costanzo,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Avvedimento,"

Phrase: "E.V."
Processing 00000000.tx.285: (1994) A polymorphism (G->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. 

Phrase: "(1994"

Phrase: ")"

Phrase: "A polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(G->"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A transition"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599156:Transition [Cell or Molecular Dysfunction]
  1000   C2700061:Transition [Activity]
   928 E C1182674:Transitional [Spatial Concept]
   928 E C1548597:Transitional [Idea or Concept]

Phrase: ")"

Phrase: "in the -78 position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "of the apolipoprotein A-I promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0085201:Apolipoprotein A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "transcription efficiency."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.286: J. 

Phrase: "J."
Processing 00000000.tx.287: Biol. 

Phrase: "Biol."
Processing 00000000.tx.288: Chem., 269, 17371-17374. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "17371-17374."
Processing 00000000.tx.289: MEDLINE Abstract 22. 

Phrase: "MEDLINE Abstract 22."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.290: Smith, J.D., Brinton, E.A. and Breslow, J.L. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Brinton,"

Phrase: "E.A."

Phrase: "and"

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "J.L."
Processing 00000000.tx.291: (1992) Polymorphism in the human apolipoprotein A-1 gene promoter region. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Polymorphism in the human apolipoprotein A-1 gene promoter region."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0678951:gene polymorphism [Genetic Function]
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.292: Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. 

Phrase: "Association of the minor allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with decreased production rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.293: J. 

Phrase: "J."
Processing 00000000.tx.294: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.295: Invest., 89, 1796-1800. 

Phrase: "Invest.,"

Phrase: "89,"

Phrase: "1796-1800."
Processing 00000000.tx.296: MEDLINE Abstract 23. 

Phrase: "MEDLINE Abstract 23."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450348:23 [Quantitative Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.297: Yamada, T., Kondo, A., Takamatsu, J., Tateishi, J. and Goto, I. 

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kondo,"

Phrase: "A.,"

Phrase: "Takamatsu,"

Phrase: "J.,"

Phrase: "Tateishi,"

Phrase: "J."

Phrase: "and"

Phrase: "Goto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.298: (1995) Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E mRNA in the brains of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.299: J. 

Phrase: "J."
Processing 00000000.tx.300: Neurosci., 129, 56-61. 

Phrase: "Neurosci.,"

Phrase: "129,"

Phrase: "56-61."
Processing 00000000.tx.301: 24. 

Phrase: "24."
Processing 00000000.tx.302: Lambert, J.C., Prez-Tur, J., Dupire, H.J. et al.) 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Prez-Tur,"

Phrase: "J.,"

Phrase: "Dupire,"

Phrase: "H.J. et al."

Phrase: ")"
Processing 00000000.tx.303: (1997) Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Distortion of allelic expression of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332482:Distortion [Anatomical Abnormality]
   748   C2919017:Distortion [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.304: Hum. 

Phrase: "Hum."
Processing 00000000.tx.305: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.306: Genet., 6, 2151-2154. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "2151-2154."
Processing 00000000.tx.307: MEDLINE Abstract 25. 

Phrase: "MEDLINE Abstract 25."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.308: Taddei, K., Clarnette, R., Gandy, S.E. and Martins, R.N. 

Phrase: "Taddei,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Clarnette,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gandy,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Martins,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.309: (1997) Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.310: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.311: Lett., 223, 29-32. 

Phrase: "Lett.,"

Phrase: "223,"

Phrase: "29-32."
Processing 00000000.tx.312: MEDLINE Abstract 26. 

Phrase: "MEDLINE Abstract 26."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.313: LaFerla, F.M., Troncoso, J.C., Strickland, D.K., Kawas, C.H. and Jay, G. 

Phrase: "LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Troncoso,"

Phrase: "J.C., Strickland,"

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521083:Kawas [Plant]

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Jay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.314: (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuronal cell death in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C2754100:neuronal cell death [Cell Function]
           neuron death
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "correlates with apoE uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "intracellular Abeta stabilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.315: J. 

Phrase: "J."
Processing 00000000.tx.316: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.317: Invest., 100, 310-320. 

Phrase: "Invest.,"

Phrase: "100,"

Phrase: "310-320."
Processing 00000000.tx.318: MEDLINE Abstract 27. 

Phrase: "MEDLINE Abstract 27."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.319: Miyata, M. and Smith, J.D. 

Phrase: "Miyata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.D."
Processing 00000000.tx.320: (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and [beta]-amyloid peptides. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E allele-specific antioxidant activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1325281:apolipoprotein activity [Molecular Function]
   827   C1148564:antioxidant activity [Molecular Function]
   799   C0003402:Antioxidant [Pharmacologic Substance]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "effects on cytotoxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "by oxidative insults"

Phrase: "and ["

Phrase: "beta]-amyloid peptides."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.321: Nature Genet., 14, 55-61. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "14,"

Phrase: "55-61."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]
Processing 00000000.tx.322: MEDLINE Abstract 28. 

Phrase: "MEDLINE Abstract 28."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.323: Bales, K.R., Verina, T., Dodel, R.C. et al.) 

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Verina,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dodel,"

Phrase: "R.C. et al."

Phrase: ")"
Processing 00000000.tx.324: (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Lack of apolipoprotein E dramatically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332268:lack [Qualitative Concept]

Phrase: "reduces"

Phrase: "amyloid beta-peptide deposition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0011560:Amyloid deposition [Pathologic Function]
   902   C1705760:Amyloid Deposition [Finding]
   812   C0333562:Deposition [Functional Concept]
   756   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   756   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.325: Nature Genet., 17, 263-264. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "17,"

Phrase: "263-264."
Processing 00000000.tx.326: MEDLINE Abstract 29. 

Phrase: "MEDLINE Abstract 29."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.327: Masliah, E., Mallory, M., Veinbergs, I., Miller, A. and Samuel, W. 

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "A."

Phrase: "and"

Phrase: "Samuel,"

Phrase: "W."
Processing 00000000.tx.328: (1996) Alterations in apolipoprotein E expression during aging and neurodegeneration. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Alterations in apolipoprotein E expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "during aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.329: Prog. 

Phrase: "Prog."
Processing 00000000.tx.330: Neurobiol., 50, 493-503. 

Phrase: "Neurobiol.,"

Phrase: "50,"

Phrase: "493-503."
Processing 00000000.tx.331: 30. 

Phrase: "30."
Processing 00000000.tx.332: Boyles, J.K., Zoellner, C.D., Anderson, L.J. et al.) 

Phrase: "Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zoellner,"

Phrase: "C.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "L.J. et al."

Phrase: ")"
Processing 00000000.tx.333: (1989) A role for apolipoprotein E, apolipoprotein A-I and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. 

Phrase: "(1989"

Phrase: ")"

Phrase: "A role for apolipoprotein E,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "apolipoprotein A-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085201:Apolipoprotein A-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "low density lipoprotein receptors in cholesterol transport"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   853   C0034821:Receptors, Low Density Lipoprotein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0023824:Low Density Lipoprotein Cholesterol [Biologically Active Substance,Steroid]
   820 E C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   814   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   778   C0065059:Receptors, Lipoprotein [Amino Acid, Peptide, or Protein,Receptor]
   774   C0065055:cholesterol lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   774   C0860920:Low cholesterol [Finding]
   774   C1326470:lipoprotein transport [Cell Function]
   757   C0599283:receptor density [Genetic Function]
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178587:density [Quantitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]

Phrase: "during regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "and"

Phrase: "remyelination of the rat sciatic nerve."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0334220:Remyelination [Organ or Tissue Function]
Processing 00000000.tx.334: J. 

Phrase: "J."
Processing 00000000.tx.335: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.336: Invest., 83, 1015-1031. 

Phrase: "Invest.,"

Phrase: "83,"

Phrase: "1015-1031."
Processing 00000000.tx.337: MEDLINE Abstract 31. 

Phrase: "MEDLINE Abstract 31."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0450355:31 [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.338: Mahley, R.W., Nathan, B.P., Bellosta, S. and Pitas, R.E. 

Phrase: "Mahley,"

Phrase: "R.W., Nathan,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Bellosta,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R.E."
Processing 00000000.tx.339: (1995) Apolipoprotein E: impact on cytoskeletal stability in neurons and the relationship to Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "impact on cytoskeletal stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "the relationship to Alzheimer's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1707789:Disease Relationship [Conceptual Entity]
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.340: Curr. 

Phrase: "Curr."
Processing 00000000.tx.341: Opin. 

Phrase: "Opin."
Processing 00000000.tx.342: Lipidol., 6, 86-91. 

Phrase: "Lipidol.,"

Phrase: "6,"

Phrase: "86-91."
Processing 00000000.tx.343: 32. 

Phrase: "32."
Processing 00000000.tx.344: Huang, D.Y., Weisgraber, K.H., Strittmatter, W.J. and Matthew, W.D. 

Phrase: "Huang,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Strittmatter,"

Phrase: "W.J."

Phrase: "and"

Phrase: "Matthew,"

Phrase: "W.D."
Processing 00000000.tx.345: (1995) Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Interaction of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "neuronal adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1154394:neuron adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "neurite morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.346: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.347: Neurol., 36, 251-257. 

Phrase: "Neurol.,"

Phrase: "36,"

Phrase: "251-257."
Processing 00000000.tx.348: 33. 

Phrase: "33."
Processing 00000000.tx.349: Hartmann, H., Eckert, A. and Muller, W.E. 

Phrase: "Hartmann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Eckert,"

Phrase: "A."

Phrase: "and"

Phrase: "Muller,"

Phrase: "W.E."
Processing 00000000.tx.350: (1994) Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "neuronal calcium signalling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0600431:calcium signalling [Cell Function]
   827   C3537152:signalling [Biologic Function]
   793 E C1710082:Signal [Phenomenon or Process]

Phrase: ":"

Phrase: "the possible relationship to beta-amyloid neurotoxicity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.351: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.352: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.353: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.354: Commun., 200, 1185-1192. 

Phrase: "Commun.,"

Phrase: "200,"

Phrase: "1185-1192."
Processing 00000000.tx.355: MEDLINE Abstract 34. 

Phrase: "MEDLINE Abstract 34."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.356: Sun, Y., Wu, S., Bu, G. et al.) 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G. et al."

Phrase: ")"
Processing 00000000.tx.357: (1998) Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Glial fibrillary acidic protein-apolipoprotein E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1325793:glial fibrillary acidic protein [Cell Component]
   734   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]

Phrase: "(apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "astrocyte-specific expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "differing biological effects of astrocyte-secreted apoE3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "apoE4 lipoproteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.358: J. 

Phrase: "J."
Processing 00000000.tx.359: Neurosci., 18, 3261-3272. 

Phrase: "Neurosci.,"

Phrase: "18,"

Phrase: "3261-3272."
Processing 00000000.tx.360: MEDLINE Abstract 35. 

Phrase: "MEDLINE Abstract 35."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.361: Ji, Z.S., Pitas, R.D. and Mahley, R.W. 

Phrase: "Ji,"

Phrase: "Z.S.,"

Phrase: "Pitas,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.362: (1998) Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglicans. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Differential cellular accumulation/retention of apolipoprotein E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1660751:cellular retention [Cell Function]
   748   C0035280:Retention [Mental Process]
   748   C0333117:Retention [Functional Concept]
   748   C1753315:retention [Cell Function]

Phrase: "mediated by cell surface heparan sulfate proteoglicans."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   778   C0699040:Cell surface [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205148:Surface [Spatial Concept]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2327880:Heparan [Biologically Active Substance]
   748   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.363: Apolipoproteins E3 and E2 greater than E4. 

Phrase: "Apolipoproteins E3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0052199:Apolipoprotein E3 [Amino Acid, Peptide, or Protein]
   861   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "greater than E4."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.364: J. 

Phrase: "J."
Processing 00000000.tx.365: Biol. 

Phrase: "Biol."
Processing 00000000.tx.366: Chem., 273, 13452-13460. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "273,"

Phrase: "13452-13460."
Processing 00000000.tx.367: MEDLINE Abstract 36. 

Phrase: "MEDLINE Abstract 36."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.368: McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.369: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.370: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.371: MEDLINE Abstract 37. 

Phrase: "MEDLINE Abstract 37."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.372: Berg, L. and Morris, J.C. 

Phrase: "Berg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "J.C."
Processing 00000000.tx.373: (1994) Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.374: In Terry, R.D., Katzman, R. and Bick, K. 

Phrase: "In Terry,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Katzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bick,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.375: (eds), Alzheimer's Disease. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Alzheimer's Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.376: Raven Press, New York, NY, pp. 

Phrase: "Raven Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "pp."
Processing 00000000.tx.377: 9-21. 

Phrase: "9-21."
Processing 00000000.tx.378: 38. 

Phrase: "38."
Processing 00000000.tx.379: Hixson, J.E. and Vernier, D.T. 

Phrase: "Hixson,"

Phrase: "J.E."

Phrase: "and"

Phrase: "Vernier,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.380: (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Restriction isotyping of human apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by gene amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017256:Gene Amplification [Genetic Function]
  1000   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   861   C0017337:Gene [Gene or Genome]
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]

Phrase: "and"

Phrase: "cleavage with HhaI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]
Processing 00000000.tx.381: J. 

Phrase: "J."
Processing 00000000.tx.382: Lipid Res., 31, 545-548. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "545-548."
Processing 00000000.tx.383: 39. 

Phrase: "39."
Processing 00000000.tx.384: Talbot, C., Lendon, C., Craddock, N., Shears, S., Morris, J.C. and Goate, A. 

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Craddock,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Morris,"

Phrase: "J.C."

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.385: (1994) Protection against Alzheimer's disease with apoE epsilon 2. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Protection against Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "with apoE epsilon 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0052198:Apolipoprotein E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439098:Epsilon [Intellectual Product]
Processing 00000000.tx.386: Lancet, 343, 1432-1433. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "343,"

Phrase: "1432-1433."
Processing 00000000.tx.387: MEDLINE Abstract 40. 

Phrase: "MEDLINE Abstract 40."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0439509:/40 [Temporal Concept]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.388: Higuchi, R. 

Phrase: "Higuchi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.389: (1990) Recombinant PCR. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Recombinant PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.390: In Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J. 

Phrase: "In Innis,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gelfand,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sninsky,"

Phrase: "J.J."

Phrase: "and"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "T.J."
Processing 00000000.tx.391: (eds), PCR Protocols. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "PCR Protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.392: Academic Press, New York, NY, pp. 

Phrase: "Academic Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "pp."
Processing 00000000.tx.393: 177-183. 

Phrase: "177-183."
Processing 00000000.tx.394: 41. 

Phrase: "41."
Processing 00000000.tx.395: Morris, J.A. and Gardner, M.J. 

Phrase: "Morris,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Gardner,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.396: (1988) Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Calculating confidence intervals for relative risks"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0009667:Confidence Intervals [Quantitative Concept]
   753   C0237529:Confidence [Mental Process]
   753   C1272706:intervals [Temporal Concept]
   753   C1704725:Confidence [Qualitative Concept]
   753   C1704726:Confidence [Mental Process]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "(odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "standardised ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "rates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.397: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.398: Med. 

Phrase: "Med."
Processing 00000000.tx.399: J., 296, 1313-1316. 

Phrase: "J.,"

Phrase: "296,"

Phrase: "1313-1316."
Processing 00000000.tx.400: *To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.401: Tel: +34 91 397 84 71; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+34 91 397 84 71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450389:71 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.402: Fax: +34 91 397 48 70; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+34 91 397 48 70"

Phrase: ";"
Processing 00000000.tx.403: Email: fvaldivieso{at} cbm.uam.es +The first two authors contributed equally to this work This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 12 Nov 1998 CopyrightOxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "fvaldivieso{at} cbm.uam.es +"

Phrase: "The first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this"

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "12 Nov 1998 CopyrightOxford University Press,"

Phrase: "1998."

